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 Coordinated motor function is achieved by proper communication between motor 
neurons and muscle fibers at a specialized synapse called the neuromuscular junction 
(NMJ). Throughout life the maintenance of the NMJ is an active process that requires the 
coordinated function of three main players: the presynaptic motor neuron terminal, the 
postsynaptic muscle fiber, and terminal Schwann cells (TSCs). Both traumatic injury and 
neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), can result in 
acute or chronic NMJ denervation, respectively. Under these conditions denervation 
triggers a regenerative response in which motor nerve terminals are stimulated to grow and 
undergo axonal sprouting as they reinnervate muscle fibers.  
Previous studies have suggested that reestablishment of neuromuscular 
connections is mediated by various axonal guidance molecules, of which Semaphorin3A 
(Sema3A) may be of particular importance. Sema3A is a secreted glycoprotein that binds 
to a plexinA-neuropilin-1 receptor complex to initiate a downstream signaling cascade that 
induces axonal repulsion. Interestingly, Sema3A mRNA upregulation at the NMJ has been 
hypothesized to create an inhibitory environment that limits axonal sprouting and dampens 
regeneration. However, a functional role for Sema3A at the NMJ has not been fully 
elucidated. 
Here, we established a quantitative and robust in vivo nerve crush model to examine 
NMJ reinnervation. Using this model, we examined how the ubiquitous loss of Sema3A or 
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Npn1 impacts regeneration of the adult NMJ. Despite efficient deletion, disruption of 
Sema3A-Npn1 signaling had no detectable effect on NMJ reinnervation after injury. Thus, 
the utility of targeting this pathway may offer more limited therapeutic potential than 
suggested by earlier studies. To identify other promising signaling pathways involved in 
nerve regeneration, we developed a rapid and unbiased method to isolate motor neuron 
specific transcripts from complex tissues in vivo. Using the RiboTag transgenic mouse 
model, we show that ribosomal complexes and their associated mRNA transcripts can be 
specifically isolated from motor neurons and analyzed to detect changes in motor neurons 
gene expression following injury and during neurodegeneration. Coupling this technique 
with RNA-seq we anticipate that this work will guide the identification and development of 




CHAPTER 1: INTRODUCTION 
 
The Neuromuscular System 
The production of complex and coordinated movements is governed by the 
neuromuscular system, which acts as a reflex arc coordinating incoming sensory 
information with the proper motor output. While the principles that govern sensory 
function have been discussed elsewhere (Lallemend and Ernfors, 2012), here we focus 
specifically on the motor output of the neuromuscular system. Contraction of skeletal 
muscle fibers generate force, forming the biological basis for movement. This is 
achieved when somatic motor neurons in the spinal cord receive input from higher order 
structures and are sufficiently depolarized to generate an action potential. That action 
potential then propagates down the motor neuron axon and results in the release of 
acetylcholine (ACh) from the axon terminal at the neuromuscular junction (NMJ). ACh 
within the synaptic cleft then binds to ACh receptors (AChRs) on the postsynaptic 
membrane of the skeletal muscle fiber, triggering depolarization of the muscle cell and 
resulting in fiber contraction. 
The smallest building block of the neuromuscular system is defined as a motor 
unit. These are comprised of a single motor neuron and all the muscle fibers it 
innervates. The size of individual motor units can vary greatly, but there is a strong 
correlation with muscle mass. For example, a motor unit within a large muscle such as 
those in the thigh, can be composed of thousands of individual muscle fibers. 
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Conversely, motor neurons innervating the extraocular muscles of the eye may only 
innervate as few as ten muscle fibers (Feinstein et al., 1955; MacIntosh et al., 2006). 
Regardless of motor unit size, once a motor neuron is activated, all the muscle fibers 
within the motor unit are stimulated to contract.  
Control of force production is regulated at the next level of organization. All the 
motor units within a given skeletal muscle make up a motor pool. Within motor pools, 
functional differences among motor unit types can be used to categorize them into three 
subtypes: (1) slow twitch, fatigue resistant (S); (2) fast twitch, fatigue resistant (FR); and 
(3) fast twitch, fatigable (FF) (Kanning et al., 2010). As the names of the different 
subtypes suggest, they exhibit a range of different contractile and electrical properties. 
For example, type S motor neurons innervate slow (type I) muscle fibers and have a 
tonic firing pattern with slower axon conduction velocities. Conversely, type FF motor 
neurons innervate fast muscle fibers (type IIa/b/x) and have a phasic firing pattern with 
faster axonal conduction velocities (Kanning et al., 2010). In addition to the contractile 
differences of their targets, the different subtypes exhibit differences in cell body size 
that translate into variations in excitability. Smaller type S motor neurons have high 
input resistance, causing them to reach activation threshold faster and fire earlier, while 
larger type FF motor neurons are much larger in size, have lower input resistance, and 
take longer to reach activation threshold (Kanning et al., 2010). Ultimately, these 
characteristics come together in a physiological context in what is known as the 
Henneman’s size principle, whereby motor units are recruited according to size with the 
smallest (type S) motor units recruited first. When stronger contractile forces are 
required, there is increased recruitment of progressively larger motor units. 
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Compared to synapses within the central nervous system, the accessibility and 
relative simplicity of the NMJ has made it an important model system to understand 
synaptogenesis and synaptic function. As such, decades of research have greatly 
contributed to our understanding of how the NMJ develops and is maintained 
throughout adult life. Although many different molecular processes and signaling 
pathways have been implicated in various aspects of NMJ function, our knowledge of 
how these complex systems respond to injury and disease is still an active area of 
investigation. 
 
Development and Maintenance of the Neuromuscular Junction 
 During embryogenesis, the initial development of motor neurons and skeletal 
muscle occur independently. All spinal motor neurons derive from a single ventral 
progenitor domain in the neural tube. This domain is specified early in development 
through inductive gradients that drive the expression of a unique combination of 
transcription factors (NKX6.1/2, Pax6, and Olig2) (Tanabe et al., 1998; Novitch et al., 
2001; Vallstedt et al., 2001). After specification, motor neuron progenitors exit the cell 
cycle and differentiate into post-mitotic motor neurons. Further specification into motor 
neuron subtypes only occurs as motor neurons extend their axons into the periphery to 
innervate distinct muscle groups. Skeletal muscle, on the other hand, is derived from 
skeletal muscle precursor cells that arise from the somites, which are paired blocks of 
paraxial mesoderm (Christ and Brand-Saberi, 2002). Once specified, committed muscle 
precursor cells migrate into the limb buds, where they differentiate into anatomically 
distinct muscle groups. 
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Two distinct phases of synapse formation are responsible for early NMJ 
development. Prior to motor innervation there is a prepatterning period that 
concentrates synaptic proteins, including AChRs, to the central region of the muscle. In 
the second phase, incoming motor axons branch as they approach the prepatterned 
muscle and nerve-secreted factors act to form and stabilize primitive synapses (Burden 
et al., 2013). Research over the past 20 years has identified three key players essential 
for this process. Muscle-specific kinase (MuSK) and LDL receptor related protein 4 
(LRP4) are two postsynaptic proteins that have been found to act in both early muscle 
prepatterning and in the later stabilization of early synapses (Kim and Burden, 2008), 
while agrin was identified as the principle factor secreted by the motor nerve (Nitkin et 
al., 1987). Taken together, in our current model of NMJ formation, AChR and other 
synaptic proteins are produced uniformly throughout the muscle fiber in a dispersed 
pattern as myoblasts fuse to form myotubes. MuSK activation, possibly by LRP4 and/or 
other muscle derived ligands, initiates muscle prepatterning of postsynaptic proteins 
(Weatherbee et al., 2006; Kim et al., 2008; Jing et al., 2009). Then, agrin released by 
the innervating motor axon binds to LRP4, strengthening the MuSK-LRP4 association 
and resulting in full MuSK activation (Kim et al., 2008). Phosphorylation of MuSK 
subsequently activates signaling cascades that result in the clustering of AChRs and 
other synaptic proteins, including MuSK and LRP4 themselves (Burden et al., 2013). 
Finally, in addition to its postsynaptic roles, LRP4 was also found to act as a retrograde 




Once primitive NMJs are formed, synaptic maturation leads to dramatic changes 
in NMJ structure and function. In postnatal muscle, multiple motor axons initially 
innervate each muscle fiber at a plaque-shaped region of postsynaptic AChRs (Sanes 
and Lichtman, 1999). Over time, through a process called synaptic elimination, one 
motor axon gradually gains territory within the synapse as other axons lose branches 
and ultimately withdrawal (Tapia et al., 2012; Smith et al., 2013). Concomitantly, the 
shape of the postsynaptic membrane matures and is sculpted into a pretzel-like 
formation (Balice-Gordon and Lichtman, 1993; Sanes and Lichtman, 2001). 
Interestingly, early studies indicate that loss of polyinnervation during synaptic 
elimination is specifically due to retraction of terminal axon branches as opposed to a 
decrease in the number of motor neurons that innervate the muscle (Brown et al., 1976; 
Balice-Gordon and Thompson, 1988). Therefore, while synaptic elimination reduces the 
overall size of motor units, the total number of motor units within a given muscle 
remains unchanged (Sanes and Lichtman, 1999). While the precise mechanism of 
synaptic elimination remains to be elucidated, it has been postulated that electrical 
activity, retrograde signals released from the muscle, and microtubule dynamics 
mediate this process (Brill et al., 2016; Tomas et al., 2017). 
Following the period of synaptic elimination and postsynaptic maturation, each 
NMJ is occupied by a single motor axon. From here, the overall geometry of the NMJ 
remains largely unchanged. In subsequent phases of muscle growth, muscle fibers 
increase in diameter and length, but the total number of fibers remains the same. 
Accordingly, it has been hypothesized that, while the early stages of synaptogenesis 
require more extensive nerve-muscle communication, later stages may rely more 
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heavily upon the tight adhesion of axon terminals to the postsynaptic apparatus (Balice-
Gordon and Lichtman, 1990). Importantly, this stability has been observed to exist 
throughout adult life. For example, time lapse imaging studies in mice have revealed 
that NMJs neither add nor lose branches throughout the lifespan of the animal 
(Lichtman et al., 1987; Balice-Gordon and Lichtman, 1990). Despite the apparent 
macroscopic stability of the NMJ, individual components of the NMJ require active 
maintenance. For example, conditional LRP4 knockout studies demonstrated that 
muscle produced LRP4 is required for both the structural and functional maintenance of 
NMJ integrity in adult mice (Barik et al., 2014). Likewise, other proteins such as alpha-1-
syntrophin (αSyn) and alpha-kinase anchoring protein (αkap) have been found to be 
necessary for the proper maintenance of AChR recycling required for proper synaptic 
transmission (Martinez-Pena y Valenzuela et al., 2011; Martinez-Pena et al., 2015). 
In addition to the motor neuron and muscle cells, a third cell type known as the 
Schwann cell is required for NMJ function. Schwann cells develop from the neural crest 
and become associated with motor axons near the somites where they then follow 
motor axons through the periphery (Sanes and Lichtman, 1999). In the adult, Schwann 
cells can be found along the length of the motor axon, where they produce the 
insulating myelin sheath that enables the high-speed propagation of action potentials to 
the axon terminal. In addition to the myelin-producing Schwann cells, a specialized set 
of non-myelinating, terminal Schwann cells have been described in the perisynaptic 
region of the NMJ (Griffin and Thompson, 2008). There, they form an insulating blanket 
over the NMJ and function to modulate synaptogenesis and synaptic transmission 
(Sugiura and Lin, 2011; Barik et al., 2016).  
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Molecular Mechanisms that Regulate Motor Neuron Pathfinding 
 Prior to the establishment of the NMJ, motor axons must first traverse great 
distances to their appropriate targets. Coordination of motor axon pathfinding during 
development is a highly complex process that is orchestrated by a series of intrinsic and 
extrinsic factors (Bonanomi and Pfaff, 2010; Stifani, 2014). Proper axon pathfinding 
relies on three major events: 1) motor axons must be directed to properly exit the 
developing spinal cord, 2) intrinsic factors must act on groups of motor neurons to 
produce anatomically distinct motor columns that project to different target regions in a 
stereotyped pattern, and 3) receptor/ligand-mediated signaling pathways must be 
activated to ensure proper navigation through the limb mesenchyme. First, while most 
motor neurons will ultimately project their axons ventrally to form the ventral roots, in the 
cervical spinal cord there is a small population of genetically distinct motor neurons 
(called dorsal motor neurons) that project axons dorsally to exit the spinal cord through 
the dorsal root (Shirasaki and Pfaff, 2002). While the precise guidance mechanisms 
underlying these path choices are unclear, there is strong evidence that the chemokine 
Cxcr4/Cxcl12 (Lieberam et al., 2005) and netrin1/DCC (Dillon et al., 2005) initiated 
signaling cascades are responsible for ventral and dorsal motor neuron projections, 
respectively. 
 Next, motor neurons organize into discrete motor columns at appropriate 
rostrocaudal locations in the spinal cord. The acquisition of motor column identity is a 
complex process involving members of the LIM homeodomain (LIM-HD) class of 
transcription factors, as well as the HOX family of HD proteins (Dasen et al., 2003; 
Bonanomi and Pfaff, 2010). In addition to the intrinsically regulated transcription factor 
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profile, extrinsic factors produced in the limb mesenchyme act in concert to assure that 
the proper axon projections occur. Although six unique motor columns are ultimately 
generated through this process, the medial motor column (MMC) that innervates the 
axial musculature and the lateral motor column (LMC) that innervates the limbs have 
been the most extensively studied (Stifani, 2014).  
As axial muscles extend the length of the body axis, the MMC motor column also 
spans the entire rostrocaudal axis of the spinal cord. Mature motor neurons of the MMC 
column uniquely express the LIM-HD protein Lhx3 (Tsuchida et al., 1994). Importantly, 
Lhx3 expression was found to be necessary and sufficient for MMC axon targeting of 
axial muscles that develop in the dermomyotome (Sharma et al., 1998). Furthermore, 
there are at least two additional mechanisms responsible for MMC axon pathfinding. 
First, Lhx3 expression was found upregulate fibroblast growth factor receptor 1 
(FGFR1), resulting in an attraction to FGF secreted by the dermomyotome (Shirasaki et 
al., 2006). Concomitantly, expression of two eph receptors (EphA3/A4) by MMC axons 
is necessary for repulsion of MMC axons from the DRG and limb buds (Gallarda et al., 
2008). 
While the MMC motor column spans the entire spinal cord, the LMC motor 
column is responsible for innervating the limb musculature and only forms at cervical 
and lumbar regions. Importantly, dorso-ventral patterning of the limb results from a 
further subdivision of the LMC into lateral (LMCl) and medial (LMCm) populations. As 
such, LMCl motor neurons that will innervate the dorsal extensor muscles have been 
found to express the LIM-HD proteins islet2 (Isl2) and lhx1, while LMCm motor neurons 
that will innervate the ventral flexor muscles express the LIM-HD protein Isl1 (Kania et 
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al., 2000). Furthermore, multiple mechanisms have been identified that help to ensure 
the fidelity of LMCl and LMCm targeting. First, LMC axons have been observed to 
pause before entering the limb bud (Lance-Jones and Landmesser, 1980; Huber et al., 
2005). Interestingly, this pause was found to be dependent on the axon guidance 
molecule Semaphorin3A (Sema3A) and its receptor neuropilin1 (Npn1), as removal of 
Sema3A signaling resulted in improper LMC axon defasciculation, premature entry into 
the limb bud, and improper dorso-ventral axon targeting (Huber et al., 2005). 
Additionally, ephrin/eph repulsive signaling has been shown to be required in both LMCl 
and LMCl populations. More specifically, the ventral mesenchyme produces ephrinA 
ligands to repel LMCl axons that express EphA4 (Kania and Jessell, 2003), while the 
dorsal mesenchyme produces ephrinB ligands to repel LMCm that express EphB1 
(Luria et al., 2008). Finally, in addition to ephrin signaling, the axon guidance molecule 
Semaphorin3F (Sema3F) and its receptor Neuropilin2 (Npn2) have been found to 
restrict LMCm axons to the ventral limb (Huber et al., 2005), while the neurotrophic 
factor glial cell line-derived neurotrophic factor (GDNF) and its receptor RET act to 
restrict LMCl axons to the dorsal limb (Kramer et al., 2006). 
 
Neuromuscular Activity in Injury and Disease  
There is a large overlap in the signaling mechanisms involved in the 
establishment of the NMJ and how it responds to both injury and disease. Interestingly, 
the central and peripheral nervous systems exhibit a well appreciated dichotomy in 
regenerative capability. Both intrinsic and extrinsic factors in the central nervous system 
actively inhibit the activation of regenerative programs, while the peripheral system is 
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capable of mounting robust regenerative responses after injury (Giger et al., 2010). For 
example, spinal cord injuries (SCI) that impede the transmission of signals required for 
motor neuron activation often repair poorly and ultimately results in paralysis, whereas 
damage to the peripheral motor nerve is usually associated with better clinical 
outcomes. However, it is important to note that although the peripheral nervous system 
is better equipped to respond to acute injuries, not all peripheral nerve injuries are 
repairable. In fact, patient disability and morbidity is a common consequence of 
peripheral nerve injuries and less than half of the patients who undergo nerve repair 
procedures fully regain motor or sensory function (Grinsell and Keating, 2014). 
Acute injury involving either the crushing or severing of peripheral nerves can 
lead to disruptions of neuromuscular activity. The type and extent of the injury, however, 
have important consequences on the resulting repair process. Initially, the response to 
any type of peripheral nerve damage is similar because the axon distal to the injury site 
must first be cleared through a process known as Wallerian degeneration. In Wallerian 
degeneration, Schwann cells near the injury site dedifferentiate into non-myelinating 
Schwann cells where they serve to both remove myelin debris (both directly and 
through the recruitment of macrophages) and secrete pro-regenerative factors that act 
on injured motor axons (Gaudet et al., 2011; Grinsell and Keating, 2014). In the next 
phase of regeneration, motor axons begin to grow in an attempt to return to their original 
targets. Importantly, after compression injury or even with minor nerve transection, the 
endoneurial sheath that surrounds the myelinated fibers remains intact and serves as a 
conduit back to the denervated motor endplates. The returning motor axons then branch 
and reinnervate vacated muscle endplates with the assistance of terminal Schwann 
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cells (Reynolds and Woolf, 1992; Kang et al., 2003; Dalkin et al., 2016). Additionally, 
like NMJ innervation during development, reinnervated NMJs are initially 
hyperinnervated by more than one motor axon. Over a period of a few weeks, newly 
innervated synapses mature and synaptic elimination results in the reestablishment of a 
one-to-one connection (Kang et al., 2003; Magill et al., 2007).  
Although regeneration in idealized circumstances like that described above can 
be quite robust, there are many situations in which severe trauma and/or inefficient 
repair leads to poor NMJ reinnervation, thereby resulting in significant deficits in motor 
function (Burnett and Zager, 2004). First, it has been well established that large scale 
nerve transections fail to regenerate because motor neuron axons become stranded 
without a path back to their target regions. Additionally, delayed regeneration has also 
been found to result in poor recovery of motor function, even though axons are able to 
reestablish synaptic contacts at the NMJ (Ma et al., 2011; Sakuma et al., 2016). Finally, 
diseases such as diabetes and normal organismal aging have been associated with 
poor peripheral nerve regeneration (Kennedy and Zochodne, 2000; Kawabuchi et al., 
2011; Kang and Lichtman, 2013). 
In addition to acute trauma caused by injury, chronic NMJ denervation resulting 
from neurodegeneration also has severe consequences on neuromuscular function. 
Motor neuron diseases (MNDs) were first described by the French neurologist Jean-
Martin Charcot in 1874. Since that time, MNDs have been described as a 
heterogeneous group of related neurodegenerative disorders that affect the motor 
neurons in the brain and spinal cord. Degeneration of these motor neurons leads to 
weakness and wasting of skeletal muscles, resulting in paralysis. Ultimately, loss of 
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muscle function leads to premature death due to difficulties in swallowing and breathing 
(Kanning et al., 2010).  
MNDs can be characterized by their pattern of onset and the type of motor 
neurons affected. The most common MND is amyotrophic lateral sclerosis (ALS), which 
involves both the upper corticospinal MNs of the motor cortex and the lower MNs in the 
spinal cord that innervate the skeletal muscle. However, other MNDs are known to have 
selective involvement of either upper MNs (primary lateral sclerosis) or lower MNs 
(progressive muscular atrophy and spinal muscular atrophy) (Bozzoni et al., 2016).  
In recent years there has been an increasing amount of attention aimed at 
understanding the complex genetic etiology of MNDs. Broadly speaking, MNDs are 
classified into two groups: familial and sporadic. Interestingly, only about 10% of all 
clinical cases are classified as familial. The vast majority of the remaining MND patients 
have a sporadic form of the disease that is thought to be caused by a combination of 
genetic, environmental, and/or other unknown factors (Renton et al., 2014). Importantly, 
we have made significant progress in identifying some of the genes whose dysfunction 
lead to ALS. They include, amongst others, Superoxide Dismutase 1 (SOD1), TAR 
DNA-binding protein (TARDBP), Fused in sarcoma (FUS), and a hexonucleotide repeat 
in C9orf72 (Renton et al., 2014). Despite unmasking some of the underlying factors in 
MND, we still do not have a firm understanding as to how mutations in the various 
genes lead to ALS symptoms. Several hypotheses have been proposed including, 
abnormal protein function and RNA processing, mitochondrial dysfunction, motor 
neuron hyperexcitability, and metabolic dysfunction (Ngo and Steyn, 2015). Finally, 
although many mechanisms of degeneration have been attributed to ALS, one 
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interesting observation has been that denervation of the NMJ occurs before any 
detectible signs of dysfunction are seen in motor neuron cell bodies. This has led to the 
‘dying-back hypothesis’, which suggests that neurodegeneration in ALS is primarily 
initiated at the motor neuron terminal and that protecting the NMJ from denervation may 
be a therapeutically valuable way to delay or even prevent neurodegeneration (Dadon-
Nachum et al., 2011). 
 
Leveraging Developmental Pathways for Motor Neuron Degeneration 
Research from many laboratories suggest that mechanisms employed by 
developing motor axons are coopted by regenerating adult motor neurons in response 
to injury and disease. For example, several neurotrophic factors including GDNF 
(discussed above), brain-derived neurotrophic factor (BDNF), and ciliary neurotrophic 
factor (CNTF) have been studied in the context of motor nerve regeneration after injury 
and in neurodegeneration resulting from MND. Numerous studies have found that loss 
of neurotrophic factor signaling impairs the regenerative response after sciatic nerve 
crush (Yao et al., 1999; Chen et al., 2016). Alternatively, enhancing neurotrophic factor 
signaling can both improve recovery of motor function after injury (Magill et al., 2010; 
Zheng et al., 2016) and extend lifespan in mouse models of ALS (Ikeda et al., 1995; Li 
et al., 2010). Similar to the neurotrophic factors, the functions of various other growth 
factors including insulin-like growth factor 1 (IGF1) and vascular endothelial growth 
factor (VEGF) have been found to improve regeneration in response to mouse models 
of injury (Islamov et al., 2004; Apel et al., 2010) and ALS (Kaspar et al., 2003; 
Dobrowolny et al., 2005; Storkebaum et al., 2005; Zheng et al., 2007). 
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Finally, the role of axon guidance molecules in axon regeneration has been of 
immense interest (Yaron and Zheng, 2007). With specific respect to the NMJ, two 
families of axon guidance molecules have received the most attention. First, a genetic 
screen in zebrafish recently identified the ephrin receptor EphA4 as a modifier of ALS 
disease progression. Further studies in mice revealed that both the genetic and 
pharmacological blockade of EphA4 signaling improved NMJ reinnervation after a 
denervating injury and significantly improved motor function and lifespan in ALS mouse 
models (Van Hoecke et al., 2012). The second axon guidance molecule that has been 
proposed to play a role at the NMJ is Sema3A. In addition to the role Sema3A plays in 
developmental LMC motor axon projections from the spinal cord (discussed above), 
Sema3A mRNA has also been described to be upregulated at the NMJ in response to 
denervation and in neurodegeneration (De Winter et al., 2006). Interestingly, the 
production of Sema3A was specifically found at NMJs on fast muscle fibers that have 
previously been associated with poor axonal sprouting after injury and increased 
susceptibility to disease (Duchen, 1970; Lowrie et al., 1982; Frey et al., 2000). Given 
that Sema3A is a well-established axonal chemorepellent that exerts its actions through 
modification of the cytoskeleton (Luo et al., 1993; Messersmith et al., 1995), the authors 
proposed that Sema3A signaling at the NMJ might create an inhibitory environment that 
dampens regenerative capacity. Additionally, a more recent study has lent more support 
to this hypothesis as it was found that systemic inhibition of the Sema3A receptor, 




Taken together, many of the findings discussed in this section demonstrate that 
exploiting developmental signaling pathways can lead to improvements in recovery from 
injury and may be protective against neurodegeneration. However, despite some 
provocative early studies suggesting Sema3A is a negative regulator of NMJ function, to 
date the functional consequences of Sema3A signaling at the NMJ remain to be 
elucidated. Therefore, to address this, in Chapter 2 we established a common peroneal 
nerve crush model that allows for the quantitative assessment of NMJ reinnervation. 
Using this model in conjunction with conditional knockout mice, we directly interrogated 
the role of Sema3A signaling in maintenance and regeneration of the adult NMJ.  
 
Global Regulation of Motor Neuron Gene Function 
 Targeted approaches are useful to investigate the function of specific signaling 
pathways, but for rapid and unbiased identification of which pathways are most relevant, 
large scale screens are necessary. This is especially true when considering the 
challenges posed by understanding complex, heterogenous neurodegenerative 
diseases like MND. With the advent of increasingly sophisticated sequencing 
technology, the pace at which genes associated with ALS have been discovered as 
accelerated dramatically (Renton et al., 2014). Importantly, this has led not only to a 
better clinical understanding of MND, but has also highlighted new pathways and 
mechanisms that might be critically important to disease pathogenesis. For example, 
the discovery that mutations in TARDBP, FUS, and C9ORF72 can result in ALS has 
implicated disruptions of RNA metabolism as being central to neurodegeneration in ALS 
patients (Droppelmann et al., 2014; Renton et al., 2014).  
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 In addition to the importance of RNA metabolism in maintenance of motor neuron 
health throughout life, over the past 20 years the role of local translation has gained 
increasing attention. Research in many different cell types has revealed that local 
translation is a widely utilized mechanism by which cells can spatially and temporally 
regulate where proteins are produced in response to different stimuli (Holt and 
Schuman, 2013). In neurons, the concept of local translation is particularly attractive 
given that they are a highly compartmentalized cell type with extensive dendritic 
arborizations and axon terminals located long distances from the cell body. Indeed, 
polyribosomes have been identified at the base of dendritic spines (Steward and Levy, 
1982) where local translation plays key roles in synaptic plasticity and learning and 
memory (Sutton and Schuman, 2006). Many studies have also found that local 
translation in axons is involved in axon guidance and growth cone collapse (Campbell 
and Holt, 2001; Wu et al., 2005; Yao et al., 2006), as well as in the axonal response to 
injury and disease (Verma et al., 2005; Willis and Twiss, 2006). To date, the extent of 
local translation in motor neurons in vivo has not been well established. However, a 
wide array of axonally localized transcripts has been reported using compartmentalized 
cell culture systems (Briese et al., 2016) and local translation in neuronal growth cones 
was found to be disrupted in an in vitro cell culture model of spinal muscular atrophy 
(SMA) (Fallini et al., 2016). 
 While we have gained extraordinary insight into how motor neurons develop and 
function in regeneration and disease, established methods of assessing motor neuron 
gene expression in vivo have been hampered by the inability to isolate them from 
surrounding cell populations in a sufficiently pure, efficient and cost-effective manner. 
17 
 
Recent advances in transgenic mouse models through the development of translating 
ribosome affinity purification (TRAP) technology has allowed for isolation of ribosomal 
bound mRNA transcripts in a cell-type specific manner. In Chapter 3, we explore how 
this technology can be harnessed to examine motor neuron specific gene expression 
and local translation. Furthermore, we also provide proof-of-principle evidence that this 




CHAPTER 2: SEMAPHORIN3A SIGNALING IS DISPENSABLE FOR MOTOR AXON 
REINNERVATION OF THE ADULT NEUROMUSCULAR JUNCTION 
 
Summary 
The neuromuscular junction (NMJ) is a specialized synapse that is formed by the 
innervation of skeletal muscle fibers by motor axons. Importantly, the maintenance of 
motor-muscle connectivity is critical for the preservation of muscle tone and generation 
of movement. Although motor axons can initiate a robust regenerative response to 
injury, severe trauma or chronic denervation brought about by neurodegenerative 
disease typically leads to inefficient repair and poor functional recovery. The axon 
guidance molecule Semaphorin3A (Sema3A) has been implicated as a negative 
regulator of motor innervation. Upon binding to a plexinA-neuropilin1 (Npn1) receptor 
complex, Sema3A initiates a downstream signaling cascade that results in axonal 
repulsion. Here, we established a reproducible nerve crush model to quantifiably assess 
motor nerve regeneration. We then used this model to investigate the role of Sema3A 
signaling at the adult NMJ. In contrast to previous findings, we found that Sema3A and 
Npn1 mRNA decrease in response to denervation, suggesting that Sema3A-Npn1 
signaling might play a role in reinnervation of the NMJ. To directly test that hypothesis, 
we used conditional knockout models to ubiquitously delete Sema3A or Npn1 from adult 
mice. Despite demonstrating that we could achieve highly efficient gene deletion, 
disruption of Sema3A-Npn1 signaling did not affect the normal maintenance of the NMJ 
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or alter the pattern of motor axon reinnervation after a denervating injury. Thus, the 
utility of targeting this pathway to improve recovery from denervating injuries may be 
more limited than suggested by earlier studies. 
 
Introduction 
Complex motor function is achieved by proper communication between the motor 
neuron and skeletal muscle at a specialized synapse called the neuromuscular junction 
(NMJ). Throughout life the maintenance of the NMJ requires the coordinated effort of 
three main structures: the presynaptic motor neuron terminal, the postsynaptic muscle 
apparatus, and terminal Schwann cells (TSCs). In healthy animals, a denervating injury 
generates a regenerative response in which both intrinsic and extrinsic factors act on 
motor nerve terminals to stimulate growth and axonal sprouting that allow for muscle 
fiber reinnervation (Kawabuchi et al., 2011). Due to their key role in establishing target 
innervation during development, axon guidance molecules have been broadly proposed 
to play roles in peripheral nerve regeneration after injury (Yaron and Zheng, 2007) and 
in response to neurodegenerative disease (Schmidt et al., 2009; Moloney et al., 2014). 
Semaphorin3A (Sema3A) is one example of an axon guidance molecule that has 
been implicated in peripheral nerve regeneration. It belongs to the large family of 
semaphorins, which are defined by the presence of a conserved Sema domain at their 
amino-terminus (Fiore and Puschel, 2003). Class III semaphorins, including Sema3A, 
are secreted glycoproteins that signal through a multimeric receptor complex. For 
Sema3A, this receptor complex is composed of a class A Plexin (PlxA1-A4) and 
Neuropilin1 (Npn1). While PlxA receptors contain a large intracellular domain that 
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initiates downstream signaling, the Npn1 receptor serves as a high affinity binding 
partner that acts to stabilize the Plexin-Sema3 interaction (Janssen et al., 2012). 
Importantly, both PlxAs and Npn1 are absolutely required for Sema3A-mediated signal 
transduction (He and Tessier-Lavigne, 1997; Kitsukawa et al., 1997; Kolodkin et al., 
1997; Takahashi et al., 1999; Gu et al., 2003; Yaron et al., 2005). 
Originally discovered as a chemorepellent that promotes sensory axon growth 
cone collapse (Luo et al., 1993; Messersmith et al., 1995), Sema3A has since been 
found to play a role in motor and sensory axon fasciculation and pathfinding during 
development (Behar et al., 1996; Taniguchi et al., 1997; Huber et al., 2005), pruning of 
hippocampal axons (Bagri et al., 2003), inhibition of cortical axon collateral branching 
(Dent et al., 2004), and control of dendritic development (Shelly et al., 2011) and 
arborization (Cheadle and Biederer, 2014). In the peripheral nervous system, previous 
studies reported that Sema3A is elevated in response to a nerve crush injury (Scarlato, 
2003; Ara et al., 2004). Furthermore, the upregulated Sema3A transcript was found to 
be specifically localized to fast type IIb/x muscle fibers, while slow type I/IIa muscle 
fibers did not express Sema3A (De Winter et al., 2006). Intriguingly, while fast and slow 
motor units are known to have different metabolic and contractile properties (Kanning et 
al., 2010), they also exhibit well documented differences in response to injury and 
neuropathology. Specifically, fast motor units are more susceptible to 
neurodegeneration resulting from amyotrophic lateral sclerosis (ALS), spinal muscular 
atrophy (SMA), and even normal organismal aging (Frey et al., 2000). Additionally, fast 
muscle fibers exhibit less axonal sprouting and tend to repair poorly, while slow fibers 
exhibit heightened axonal sprouting and repair more efficiently (Duchen, 1970; Lowrie et 
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al., 1982; De Winter et al., 2006). Taken together, this previous work suggests a model 
by which the presence of Sema3A at the NMJ on fast muscle fibers generates a growth-
inhibitory environment that may serve to reduce axonal sprouting and repair in response 
to injury. 
In this study, we sought to directly test whether Sema3A signaling plays a 
functional role during reinnervation of the NMJ. To this end, we developed and 
characterized a nerve crush model that is highly reproducible and allows for the 
quantification of distinct phases of NMJ reinnervation. To avoid deficits due to the 
established role of Sema3A in the development of the peripheral nervous system, we 
generated conditional knockout mice that allowed for the ubiquitous deletion of either 
Sema3A or Npn1 from adult mice. Contrary to the proposed role of Sema3A predicted 
by previous studies, we found that Sema3A signaling appears to be largely dispensable 
for normal NMJ reinnervation in response to injury. 
 
Results 
To directly examine whether Sema3A signaling plays a role in NMJ reinnervation, 
we needed a reproducible nerve crush model that would allow us to quantify the 
different phases of NMJ reinnervation. To this end, we chose to perform the nerve crush 
on the common peroneal branch of the sciatic nerve that innervates the anterior 
muscles of the distal hindlimb. The advantage of this approach is that it allows us to 
examine reinnervation in the extensor digitorium longus (EDL), which is a thin muscle 
amenable to systematic and thorough analysis. Additionally, based on previously 
published studies, we could also predict the approximate time course of initial muscle 
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denervation and subsequent reinnervation (Magill et al., 2007; Bauder and Ferguson, 
2012; Dalkin et al., 2016). The experimental design we used to fully characterize this 
nerve crush model is illustrated in Fig. 2.1A. Briefly, a common peroneal nerve crush 
and a contralateral sham surgery were performed on wild-type mice. Injured and control 
EDL muscles were then collected at different time points (D2-D30) and processed to 
systematically collect longitudinal sections throughout the entirety of the muscle (see 
Materials and Methods). Finally, sections were immunostained and analyzed to quantify 
the extent of NMJ denervation or reinnervation.  
To ensure that the nerve crush injury induced a complete withdrawal of motor 
axons from the EDL muscle, we utilized Thy1CreERT2-EYFP mice that exhibit strong YFP 
expression in peripheral nerves. Sham-injured and denervated EDLs were collected two 
days after nerve crush and whole mount imaging was used to broadly examine 
denervation after injury. As expected, intact YFP+ innervation was observed in sham-
injured EDLs, while a dramatic and uniform loss of YFP signal was apparent two days 
after nerve crush (Fig. 2.1B). In addition to loss of innervation we also confirmed that 
newly reinnervating motor nerves were initially unmyelinated following common 
peroneal nerve crush (Fig. 2.1C). D4 sham-injured and denervated EDLs were stained 
with a combination of bungarotoxin (BTX) and βIII-tubulin (green), S100 calcium binding 
protein (S100b, blue) and myelin basic protein (MBP, magenta). Sham-injured 
endplates exhibited normal innervation and myelination patterns (Fig. 2.1C, left panels). 
More specifically, βIII-tubulin+ motor nerves were seen innervating BTX labeled 
endplates. While both S100b and MBP labeled the myelin sheath coating axons as they 
innervate the NMJ, only S100b was observed to extend into the endplate region. In 
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contrast, at D4 after nerve crush, reinnervating βIII-tubulin+ motor nerves exhibited a 
marked reduction of S100b and only fractured pockets of MBP staining was evident 
(Fig. 2.1C, right panels). 
After characterizing that this injury model could yield reproducible and uniform 
denervation, we sought to devise a scoring system that would allow us to quantify 
different degrees of NMJ reinnervation. BTX (magenta) was used to identify the 
endplate region, while βIII-tubulin (green) and synapsin (blue) were used as markers for 
nerve reinnervation and presynaptic differentiation, respectively. Six different 
morphological categories were created to reflect the innervation status of individual 
NMJs (Fig. 2.1D): completely denervated (Score 0), motor nerve is approaching, but not 
yet innervating an endplate (Score 1), less than 50% of the endplate area is covered 
(Score 2), more than 50% of the endplate area is covered (Score 3), full coverage but 
immature (Score 4), and completely reinnervated (Score 5). 
Next, we applied this scoring system to quantify reinnervation in C57BL/6 wild-
type mice at various time points following nerve crush. Importantly, the total number of 
individual NMJs analyzed per mouse was consistent across all time points, with 
approximately 200-300 in plane NMJs analyzed per mouse (Fig. 2.1E). Furthermore, 
graphing the percent of NMJs scored 0-5 points based on βIII-tubulin (Fig. 2.1F) and 
synapsin (Fig. 2.1G) staining revealed that this scoring system could indeed identify 
unique phases of denervation and reinnervation occurring at different time points. 
Almost all NMJs at D2 after injury were completely denervated and received a score of 
zero. By D4 the motor nerve started reentering the EDL and a few endplates were 
beginning to be reinnervated, but no presynaptic differentiation was observed (all 
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synapsin based scores were zero). From D7 to D14 increasingly more NMJs became 
reinnervated, while from D14 to D30 maturation of the innervating motor nerve could be 
observed as scores shifted from 3 or 4 to an increasing number of 5s. Although 
innervation at D30 began to approach that observed in sham-injured EDLs, full recovery 
had not yet occurred. Taken together, our data demonstrates that we can use this 
common peroneal nerve crush model to carefully interrogate motor axon regeneration, 
synaptogenesis and remyelination after nerve injury.  
 
Sema3A Signaling Family Gene Expression 
Previous work examining Sema3A signaling at the NMJ found that Sema3A 
mRNA was not detectable in normally innervated muscle. However, a dramatic 
upregulation of Sema3A was observed after nerve crush injury in the fast-twitch fiber 
types of the gastrocnemius (GP) muscle, while the slow-twitch fibers of the soleus (Sol) 
muscle showed no response (De Winter et al., 2006). Like the GP, the EDL is 
predominately composed of fast-twitch fibers. Therefore, we reasoned that patterns of 
Sema3A signaling should be similar in the two muscles. To directly examine this, we 
isolated RNA from wild-type GP, Sol, and EDL muscles and from the spinal cord (SC). 
RT-qPCR was then used to analyze Sema3A and its signaling partners at the transcript 
level (Fig. 2.2). As a control for our three muscles of interest, we examined the 
expression of different isoforms of myosin heavy chain (Myhc) that are known to be 
more representative of fast- or slow-twitch fiber types (Agbulut et al., 2003). As 
expected, the Sol muscle exhibited a strong enrichment in the slow myosin isoforms 
Myhc-I (GP, p = 0.006; EDL, p = 0.0033) and Myhc-IIa (GP, p = 0.015; EDL, p = 
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0.0016), while the fast isoform Myhc-IIb was dramatically upregulated in the GP (p ˂ 
0.0001) and the EDL (p ˂ 0.0001). Furthermore, a similar level of Myhc-IId/x was 
observed in all three muscle groups and the embryonic Myhc (Mych-EMB) was barely 
detectable in any of the adult muscles (Fig. 2.2A). 
Once we established that proper Myhc isoform profiles were expressed in the 
different muscle groups, we examined the expression levels of Sema3A, PlxA, and Npn 
transcripts. In contrast to what had been previously reported (De Winter et al., 2006), 
we could reproducibly detect Sema3A mRNA in uninjured adult skeletal muscle (Fig. 
2.2B). More specifically, we found that Sema3A was expressed at a similar level in the 
GP (1.00 ± 0.17), EDL (1.30 ± 0.01), and SC (2.635 ± 0.55), while a significant 
reduction of transcript was observed in the slow-twitch Sol (0.295 ± 0.06) muscle 
compared to the GP (p = 0.014), EDL (p ˂ 0.0001) and SC (p = 0.019). Additionally, 
analysis of PlxA1-A4 (Fig. 2.2C) and Npn1-2 (Fig. 2.2D) family members revealed that 
all receptor components were generally expressed at similar levels within the different 
muscles examined, except for PlxA1, which had the highest expression in the GP and 
lowest expression levels in the Sol. 
To examine if Npn1 and Sema3A transcript levels change in response to a 
denervating injury, a common peroneal nerve crush was performed on wild-type mice. 
Uninjured (UI) and denervated EDLs were then collected at different time points (D7-
D50) after injury. In some cases, a nerve cut was performed instead of a nerve crush 
and tissue was collected at D21 to examine how gene expression was altered in the 
absence of reinnervation. Several control genes were used to monitor the progression 
of the degenerative and regenerative response to the nerve crush. Muscle-specific 
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kinase (MuSK), one of the main components of the postsynaptic apparatus, and 
Growth-associated protein 43 (GAP43), a gene associated with regenerating axons and 
Schwann cells, have both previously been reported to be induced by denervating 
injuries (Bowen et al., 1998; Xu et al., 2008; Li et al., 2010). Conversely, myelin protein 
zero (MPZ) and S100b are expressed by myelinating cells and have been reported to 
be reduced following nerve crush (Gupta et al., 1988; Mitchell et al., 1990; Magill et al., 
2007; Li et al., 2010). Overall, we observed similar trends in gene expression in 
response to a common peroneal nerve crush to what has been reported for other injury 
models. MuSK was significantly upregulated at D7 after nerve crush (UI, 1.00 ± 0.06; 
D7, 5.03 ± 0.69, p < 0.0001), but returned to baseline by D21 (D21, 0.84 ± .07, n.s.). 
Furthermore, preventing reinnervation resulted in a prolonged upregulation of MuSK 
mRNA (8.50 ± 0.69, p < 0.0001) at the D21 time point (Fig. 2.3A). Similar to MuSK, a 
strong induction of GAP43 mRNA was observed at D7 time point (UI, 1.00 ± .07; D7, 
5.57 ± 0.86, p < 0.0001) and when reinnervation was blocked (D21 cut, 5.39 ± 0.3654, p 
< 0.0001); however, it exhibited a slower return to baseline uninjured levels (D21, 4.77 ± 
0.62; D30, 1.98 ± 0.35; D50, 1.46 ± 0.10) over the 50-day time course (Fig. 2.3B). We 
also found that MPZ (Fig. 2.3C) and S100b (Fig. 2.3D) exhibited similar changes in 
gene expression in response to denervation. In both cases a significant reduction in 
gene expression was observed at the D7 time point (MPZ: UI, 1.00 ± 0.06, D7, 0.03 ± 
0.02, p < 0.0001; S100b: UI: 1.00 ± 0.04, D7, 0.30 ± 0.08, p < 0.0001) with levels 
normalizing to that observed in the uninjured EDL by D21 (MPZ: D21, 2.61 ± 0.83; 
S100b: D21, 0.93 ± 0.15). Additionally, the restoration of MPZ and S100b mRNA levels 
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at the D21 time point could be prevented by prolonged denervation after nerve cut 
(MPZ: 0.06 ± 0.06, p < 0.0001; S100b: 0.29 ± 0.6). 
Based on previous studies (Scarlato, 2003; Ara et al., 2004; De Winter et al., 
2006) and the fact that we detected similar levels of Sema3A transcript in GP and EDL 
muscles (Fig. 2.2B), we hypothesized that nerve crush would result in increased 
expression of Sema3A mRNA in the EDL muscle. However, we observed that at D7 
after a common peroneal nerve crush, there was a significant reduction in both Npn1 
(UI, 1.00 ± 0.04, D7, 0.51 ± 0.04, p < 0.0001) and Sema3A (UI, 1.00 ± 0.04, D7, 0.24 ± 
0.03, p < 0.0001) mRNA (Fig. 2.3E,F). By D30 after the initial injury, Npn1 levels 
returned to baseline (0.97 ± 0.06), while Sema3A mRNA levels partially rebounded by 
D21 after injury (0.57 ± 0.08, p = 0.0001), but remained significantly reduced compared 
to the uninjured control muscle throughout the entire time course (D30, 0.59 ± 0.08, p = 
0.04; D50, 0.50 ± 0.04, p = 0.003). Altogether, these results suggest that there is 
decreased Sema3A signaling in response to denervation. Despite these unexpected 
findings, whether Sema3A signaling plays a functional role in the process of 
reinnervation remained an unanswered question. 
 
Direct Examination of Npn1-Sema3A Signaling during Motor Reinnervation of the 
NMJ. 
To directly test whether Sema3A signaling is required for reinnervation of the 
NMJ we used conditional knockout mice to delete Npn1 in adult mice (Fig. 2.4). As the 
high-affinity binding receptor for Sema3a, deletion of Npn1 renders cells insensitive to 
secreted Sema3A (Kitsukawa et al., 1997; Gu et al., 2003). Npn1fx/fx mice were crossed 
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to the Ubiquitin-CCreERT2 (UBCCreERT2) mouse line to generate Cre-negative littermates or 
Cre-positive conditional mutants (Npn1UBC). Tamoxifen (TMX) injections were then 
administered to initiate Cre-mediated recombination and after a resting period of 12-15 
days, a common peroneal nerve crush or contralateral sham injury were performed. The 
EDL muscle was then collected at various time points and the extent of reinnervation 
was quantified (Fig. 2.4A). In some cases, Npn1UBC mice were treated with corn oil (CO) 
and used as a vehicle control. Because Cre-negative and CO-treated Npn1UBC mice 
behaved similarly by all parameters examined, both groups were combined into one 
Npn1WT control littermate group. GP muscle and spinal cord tissue were collected from 
all mice examined in reinnervation analyses and were used to validate that an efficient 
and ubiquitous deletion of Npn1 was achieved. Analysis of Npn1 transcript levels by RT-
qPCR demonstrated that Npn1UBC mice had dramatically lower levels of Npn1 
expression than littermate controls (% Knockdown: GP, 93.66% ± 1.20; SC, 91.44% ± 
3.69; Fig. 2.4B). Furthermore, immunoprecipitation of Npn1 followed by immunoblotting 
showed that there was no detectable Npn1 protein in Npn1UBC muscle (Fig. 2.4C) or 
spinal cord (Fig. 2.4D). 
Once efficient knockdown of Npn1 was established, we analyzed reinnervation at 
the various time points after nerve crush. Similar to what we observed in wild-type mice 
(Fig. 2.1E), ~200-300 NMJs were scored at the various time points in Npn1WT and 
Npn1UBC mice (Fig. 2.4E). Additionally, we analyzed the sham-injured EDLs at the D30 
time point and found no significant differences in the observed βIII-tubulin (Fig. 2.4F) or 
synapsin (Fig. 2.4G) scores between Npn1WT and Npn1UBC mice. Together, these 
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results reveal that Npn1 does not appear to be integral to either the postsynaptic 
apparatus after injury or for the normal maintenance of the NMJ. 
To determine whether Npn1 was involved in reinnervation, we examined βIII-
tubulin (Fig. 2.4H, I) and synapsin (Fig. 2.4J, K) staining over the entire 50 day time 
course. Npn1WT control littermates exhibited a pattern of reinnervation that closely 
resembled that observed in wild-type C57BL/6 mice (see Fig. 2.1F, G). Furthermore, the 
deletion of Npn1 did not appear to drastically impact the process of reinnervation in 
Npn1UBC mice. However, at the D30 time point, we did observe a shift towards lower 
reinnervation scores with Npn1UBC mice exhibiting more partially innervated NMJs 
(Synapsin Score 3: Npn1WT, 9.87% ± 2.50%; Npn1UBC, 17.67% ± 2.38%) and less fully 
innervated NMJs (Synapsin Score 5: Npn1WT, 60.00% ± 8.08%; Npn1UBC, 42.03% ± 
2.65%). To examine this more closely, the reinnervation data for scores 3-5 were 
replotted to directly compare Npn1WT and Npn1UBC genotypes (Fig. 2.4L, M). 
Examination of the data in this manner revealed that there is a significant reduction (**p 
= 0.0037) of NMJs that received a fully reinnervated score of 5 based on synapsin 
staining at the D30 time point. Overall, our data suggests that loss of Npn1 may slightly 
delay synaptic maturation of the motor nerve at the reinnervating NMJ. This delay, 
however, is only temporary since both Npn1UBC and Npn1WT mice exhibit similar levels 
of presynaptic synapsin staining at D50 after injury. 
In addition to examining reinnervation following Npn1 deletion, we also assessed 
the effect of Sema3A deletion on NMJ reinnervation. Sema3Afx/fx and UBCCreERT2 mouse 
lines were crossed to generate Cre-negative littermates or Cre-positive conditional 
mutants (Sema3AUBC). TMX or CO injections were then administered to induce Cre-
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mediated recombination prior performing a common peroneal nerve crush. RT-qPCR 
and immunoblotting were again used to examine Sema3A gene and protein expression. 
Sema3AUBC mice treated with TMX exhibited significant knockdown of Sema3A 
transcript compared to Cre-negative control littermates (% Knockdown: GP, 94.12% ± 
0.69; SC, 89.29% ± 3.71). We also observed that CO-treated Sema3AUBC mice showed 
a consistent, but partial reduction in Sema3A levels (% Knockdown: GP, 57.91% ± 7.27; 
SC, 66.39% ± 7.74; Fig. 2.5A). Deletion of Sema3A protein was also demonstrated 
through immunoblotting. A protein band corresponding to the expected molecular 
weight of Sema3A (95-105 kDA) was detected in Sema3AWT mice, but was absent in 
TMX-treated Sema3AUBC GP muscle (Fig. 2.5B). Although the partial reduction of 
Sema3A mRNA in CO-treated Sema3AUBC mice did not appear to translate into an 
observable reduction of Sema3A protein (Fig. 2.5B), we excluded that control group 
from subsequent reinnervation analysis. Importantly, Sema3A deletion prior to a 
denervating injury did not impact reinnervation of the NMJ. Loss of Sema3A did not alter 
the number of scored NMJs at the various time points examined (Fig. 2.5C). 
Furthermore, no differences in reinnervation were observed at any time point (Fig. 2.5D 
– 5I).  
 
Loss of Npn1 does not Disrupt Remyelination  
Because it has been reported that terminal Schwann cells express Sema3A (De 
Winter et al., 2006), we explored whether the loss of Npn1 disrupted the process of 
myelination on newly extended motor axons. Npn1WT and Npn1UBC EDL sections from 
the D7 and D21 time points were immunolabeled with βIII-tubulin and BTX (green) to 
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visualize the motor nerve and the postsynaptic endplate region, while S100b (blue) and 
MBP (magenta) staining were used to visualize myelin proteins. Both innervation and 
myelination appeared normal in sham-injured sections (Fig. 2.6A), while varying 
degrees of NMJ reinnervation can be appreciated in both Npn1WT (Fig. 2.6B) and 
Npn1UBC mice (Fig. 2.6C) at the D7 time point after nerve crush. Furthermore, 
reinnervating motor axons of both genotypes exhibited similar levels of myelination as 
evidenced by the reduction in S100b staining and the absence of MBP. Finally, by the 
D21 time point, Npn1WT (Fig. 2.6D) and Npn1UBC (Fig. 2.6E) motor axons displayed 
strong S100b and MBP immunofluorescence, indicating that the deletion of Npn1 did 
not affect the process of remyelination. 
 
Discussion 
It has long been appreciated that peripheral nerves exhibit a remarkable degree 
of plasticity and regenerative ability after injury. However, depending on the extent of 
the trauma after an acute injury and in cases of chronic denervation brought about by 
neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), the capacity 
for peripheral nerve regeneration can be greatly limited. Consequently, failures in proper 
reinnervation of skeletal muscle lead to a reduction in neurotransmission, which in turn 
dampens the trophic support required for motor neuron and muscle fiber survival. 
Therefore, deciphering the molecular mechanism that underlies the regenerative 
response of motor axons has been a major focus within the field. Furthermore, it has 
been hypothesized that the exploitation of these pathways will yield improvements in 
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motor axon regeneration that maximize muscle reinnervation in order to prevent 
functional deficits resulting from long-term denervation. 
Although the regenerative response produced by denervation has already proven 
to be complex, many studies are beginning to tease apart the various signaling 
molecules that are likely playing key regulatory roles (Schmidt et al., 2009). Through its 
role as an axonal chemorepellent during development and its pattern of expression after 
injury at the NMJ, Sema3A signaling has been proposed to act as a negative regulator 
of motor axon reinnervation of the NMJ (De Winter et al., 2006). However, the functional 
consequences resulting from altered Sema3A signaling had not been previously 
examined. 
Here, we fully characterized the regenerative response following a common 
peroneal nerve crush and demonstrated how it allows for the analysis of motor nerve 
reinnervation in a reproducible and highly quantifiable manner (Fig. 2.1). Using this 
model, we directly examined how motor axon terminals respond to a denervating injury 
in the absence of Sema3A signaling by employing conditional knock-out mice to delete 
Npn1, the high-affinity Sema3A binding receptor (Fig 2.4), or Sema3A itself (Fig 2.5). 
Despite demonstrating that we could achieve a highly efficient and ubiquitous gene 
knock-down, perturbing Sema3A signaling did not alter the time course of muscle 
reinnervation or myelination after injury. 
While our study indicates that Sema3A signaling is not a necessary component 
of motor axon regeneration, we did observe some differences in Sema3A expression 
that conflict with what has previously been reported in other studies. Using a rat sciatic 
nerve crush model, De Winter et al., (2006) found that Sema3A is not normally 
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expressed in uninjured skeletal muscle. However, after a denervating injury, they found 
a dramatic upregulation of Sema3A mRNA in fast-twitch gastrocnemius muscle fibers, 
while the same response was not observed in the predominately slow-twitch soleus 
muscle. In contrast, we observed the opposite pattern of Sema3A expression in the 
fast-twitch EDL muscle after a common peroneal nerve crush. Namely, we could 
consistently detect Sema3A transcript in the uninjured adult EDL (Fig 2.2B) and we 
observed a significant decrease in Sema3A after nerve crush injury (Fig 2.2F). Although 
it is not directly apparent what factor or factors underlie these discrepancies, it may be 
possible there are species-specific differences between the two models. Another 
possibility is that dorsoventral patterning may lead muscles of the posterior 
(gastrocnemius) and anterior (EDL) leg compartment to utilize different signaling 
pathways in different ways. Finally, it is also interesting to note that data from both 
studies similarly suggests Sema3A signaling may be playing a larger role in fast-twitch 
muscle fibers. Although we did not examine how Sema3A levels are altered in the 
soleus muscle after injury, in uninjured muscle we found ~3-4 fold lower levels of 
Sema3A mRNA compared to that observed in the fast-twitch GP and EDL muscles (Fig 
2.2B). What accounts for differences in Sema3A expression in different muscle groups 
and the significance of those differences, if any, remains an open question. 
Recently, it has been proposed that Npn1-Sema3A signaling may play a role at 
the postnatal NMJ (Helmbrecht et al., 2015; Saller et al., 2016). However, for those 
studies the authors used the Olig2 promoter to conditionally delete Npn1 from motor 
neurons. Because the Olig2 promoter turns on very early in development (Masahira et 
al., 2006), it is not possible resolve whether the observed phenotype is due to an earlier 
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axon pathfinding defect or the loss of active Npn1-Sema3A signaling at the NMJ. 
Therefore, to our knowledge, this is the first published study to directly examine how the 
adult NMJ responds to the absence of Sema3A signaling. We addressed this question 
by examining innervation in sham-injured EDLs at the D21 time point and overall found 
no effect on the NMJ histology after Npn1 deletion. Both the total number of scored 
NMJs and their innervation status (as scored by nerve βIII-tubulin and the presynaptic 
marker synapsin) were similar among Npn1UBC and Npn1WT mice (Fig.2.4F-G). Lastly, it 
is important to note that while this analysis was performed at the D21 time point, we can 
estimate that Npn1 was ubiquitously deleted for ~1 month (see Fig. 2.4A). Furthermore, 
from previous studies it is known that acetylcholine receptors in uninjured skeletal 
muscle have a half turnover rate of about 10 days (Loring and Salpeter, 1980). 
Therefore, enough time should have elapsed to determine if Npn1 plays a major role in 
the maintenance of the NMJ.  
An interesting observation we made following Npn1 deletion was that at the D30 
time point there was a statistically significant decrease in the number of NMJs that 
received the highest innervation score based on synapsin staining (Fig 2.4M). However, 
the same effect was not observed after Sema3A deletion. This, combined with our 
finding that Npn1 levels decrease after nerve crush and do not return to uninjured levels 
until the D30 time point, suggest that signaling through the Npn1 may play a minor role 
in the maturation of the presynaptic motor nerve after injury. It is also noteworthy that 
these observations fit with recently published studies of Npn1-Sema3A signaling at the 
NMJ. More specifically, a pharmacological inhibition of the Npn1 receptor was shown to 
delay denervation and prolong lifespan in an ALS mouse model (Venkova et al., 2014), 
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while mice engineered to express a mutated form of Sema3A protein did not display any 
defects in response to denervation or the neurodegenerative disease process (Moloney 
et al., 2017). 
Taken together, the evidence to date suggests that Sema3A signaling is 
dispensable in the context of adult motor nerve regeneration. However, signaling 
through the Npn1 receptor may play a transient role in mediating NMJ synaptic 
maturation. Interestingly, Npn1 contains multiple extracellular domains that have been 
suggested to mediate a diverse array of protein interactions (Fujisawa et al., 1997; 
Nakamura and Goshima, 2002). For example, the vascular endothelial growth factor 
(VEGF) pathway has been well established to exert its signaling actions through the 
Npn1 receptor (Soker et al., 1998). Additionally, VEGF signaling has also been found to 
be protective against neurodegeneration in ALS mouse models (Storkebaum et al., 
2005; Zheng et al., 2007), suggesting that VEGF-Npn1 signaling is an avenue that 
warrants further exploration. Finally, one intriguing possibility is that there is a 
compensatory pathway activated in the absence of Sema3A-Npn1 signaling. While we 
cannot specifically rule out this possibility, our work suggests that direct targeting of 
these pathways will not be a substantial avenue for future therapeutic research on nerve 
regeneration after injury. However, by continuing to better understand the complex 
processes that regulate muscle reinnervation we move closer to uncovering new 
strategies to promote motor axon regeneration and prevent functional deficits 





Animals. All housing and procedures performed on mice were approved by the 
Institutional Animal Care and Use Committee (IACUC) of the University of Michigan. 
Wild-type C57BL/6J (000664), Thy1CreERT2-EYFP (012708), and UBCCreERT2 (007001) mice 
were obtained from Jackson Laboratories (Bar Harbor, ME). Npn1fx/fx (Gu et al., 2003) 
or Sema3Afx/fx (Riken Bioresource Center, RBRC01106) conditional mice were crossed 
with UBCCreERT2 mice to generate UBCCreERT2;Npn1fx/fx (Npn1UBC) and 
UBCCreERT2;Sema3Afx/fx mice (Sema3AUBC). All mice were genotyped according to 
publicly available protocols except for Sema3A conditional mice. New primers (forward 
5’-CACTGGGATTGCCTGTCTTT-3’, and reverse 5’-ACGGAGCAAGCACACAGCTA-3’) 
were designed to detect a 363bp wild-type band and/or a 400bp mutant band. For all 
experiments, both male and female mice were analyzed in similar numbers. 
  
Conditional Deletion. Tamoxifen (TMX, Sigma-Aldrich) was administered at a dose of 
0.25mg/g body weight to Npn1UBC or Sema3AUBC mice by oral gavage once a day for 5 
days. Mice were then given a resting period of 12-15 days to allow for complete Cre-
mediated recombination prior to performing nerve crush experiments (see Figure 2.1). 
In all experiments two types of control littermates were used: 1) Cre wild-type 
(UBCCreERT2 negative mice treated with TMX) and 2) vehicle only [UBCCreERT2 mice 
treated with corn oil (CO)]. For the Npn1-conditional deletion, both control groups 
behaved similarly and therefore all results were averaged and displayed as one wild-
type control group (Npn1WT). For the Sema3A-deletion, CO-treated mice exhibited a 
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partial reduction in Sema3A transcript levels (see Fig. 2.5A), so only Cre wild-type mice 
(Sema3AWT) were used. 
 
Common Peroneal Nerve Crush. Mice were deeply anesthetized with 2-3% isoflurane 
mixed with oxygen and the surgical site was shaved and disinfected. A small incision 
was made along the lateral aspect of the distal hindlimb from just above the ankle to just 
below the knee. A dissecting microscope was used to expose the common peroneal 
nerve through a small opening between the anterior compartment (tibialis anterior) and 
the posterior compartment (lateral gastrocnemius). The exposed nerve was then 
crushed by applying pressure with a pair of forceps for 40 sec. Following the crush 
procedure, the site where the anterior and posterior muscles were separated was 
closed with a suture and then the skin was sutured at the incision site. In a small 
number of experiments, a nerve cut was performed instead of a nerve crush. In these 
instances, the same procedure was performed except that a 3-5mm piece of nerve was 
excised as opposed to being crushed with forceps. 
 
RNA Isolation and RT-qPCR. Tissues were harvested and snap frozen in liquid 
nitrogen. Homogenization was performed in TRIzol reagent (ThermoFisher) using a 
TissueLyser II (Qiagen) set at 30Hz for 5 min. Samples were then centrifuged at 12,000 
x g for 10 min at 4°C. RNA was isolated by phase separation with chloroform followed 
by isopropanol precipitation (per the manufacture’s protocol). In some instances, RNA 
was isolated with the Direct-zol RNA MiniPrep Kit (Zymo Research) according to 
manufacture guidelines. The concentration of isolated RNA was determined by 
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NanoDrop (ThermoFisher Scientific) and 1µg cDNA was synthesized using the 
Superscript III First-Strand Synthesis SuperMix kit (Invitrogen). RT-qPCR was 
performed using the 7900HT Fast Real-Time PCR System (Applied Biosystems) with 
the appropriate primer set (Table 1) and FastStart Universal SYBR Green Master Mix 
(Roche). B2M was used as an internal control for all dCT calculations and gene 
expression was calculated relative to the control condition. 
 
Npn1 Immunoprecipitation. Muscle or spinal cord samples were dissected and placed 
into immunoprecipitation buffer (10% glycerol, C0mplete protease inhibitors (Roche), 
and sodium vanadate in Tris buffered saline (TBS), pH 6.8). Tissues were homogenized 
with the Tissue Lyser II (Qiagen) set at 30 Hz for 5min. Samples were then detergent 
extracted by the addition of nonidet p-40 (1% final concentration) followed by constant 
rotation for 30 min at 4°C and insoluble material was removed by centrifugation for 5 
min at maximum speed in a microfuge. Before Npn1 immunoprecipitation (IP), samples 
were first precleared with a mixture of protein A/G agarose beads (Roche) for 1 hr. 
Next, a control IP was performed in which samples were incubated with a non-specific 
goat control antibody and protein A/G beads for 2 hrs. Finally, the Npn1 IP was 
performed overnight with a Npn1 antibody (AF566, R&D Systems) and protein A/G 
beads. For all incubations, samples were left under constant rotation at 4°C. The next 
day samples were lightly centrifuged (5000 rpm, 5 min) and the supernatant was 
collected and denatured in 2x sodium dodecyl sulfate (SDS) sample buffer (20% 
glycerol, 4% SDS, 1% β-mercaptoethanol, and bromophenol blue in TBS, pH 6.8) by 
heating for 10 min at 100°C. Meanwhile, the immunoprecipitated product was washed 
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three times with immunoprecipitation buffer followed by denaturation in the same 
manner as described for the supernatants. 
 
Protein Isolation for Sema3A Immunoblotting. We used many different methods of 
protein isolation and various Sema3A antibodies to try and demonstrate effective 
knockdown of Sema3A protein Sema3AUBC mice. However, most methods resulted in 
obtaining a non-specific protein band in the reported 95-105 kDA molecular weight 
range. The only methodology that we found to be successful was when protein was co-
purified with RNA using the Direct-zol RNA MiniPrep Kit (Zymo Research). With this kit, 
after RNA binds to the RNA-binding cup, protein in the flow-through was precipitated 
with ice-cold acetone for 30min on ice. Samples were then centrifuged for 10 min at 
max speed to pellet the protein precipitate. The protein was then washed with 100% ice-
cold ethanol, centrifuged again, and resuspended in water. Finally, the protein was 
denatured by adding an equal volume of 2x SDS sample buffer and heating for 10 min 
at 100°C. 
 
Immunoblotting. All samples were resolved on a 7% (SDS)-polyacrylamide gel 
electrophoresis (SDS-PAGE) gel and transferred to polyvinylidene fluoride (PVDF) 
membranes. Membranes were blocked in 4% Milk in TBS-T (Tris buffered saline, pH 7.4 
and 0.1% Tween-20) for 1hr at room temperature. Primary antibodies [α-Tubulin 
(1:30,000, T9026, Sigma-Aldrich), Actin (1:1,000, SC-1616-G, Santa Cruz), Npn1 
(1:1,000, AF566, R&D Systems), or Sema3A (1:1,000, ab23393, Abcam)] were diluted 
in 3% bovine serum albumin (BSA) and incubated overnight at 4°C. The following day, 
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membranes were washed and incubated with appropriate horseradish peroxidase 
(HRP)-linked secondary antibodies (1:10,000) in 3% BSA (Jackson ImmunoResearch) 
followed by visualization with a chemiluminescent substrate (Thermo Scientific). 
 
Tissue Preparation. EDL muscles were fixed in 4% paraformaldehyde (Electron 
Microscopy Sciences) for 10min at room temperature. Tissues were then washed 
3x20min in phosphate-buffered saline (PBS) and soaked overnight in 30% sucrose at 
4°C. Muscles were embedded in O.C.T compound (Tissue-Tek) and frozen at -80°C. 
50µm longitudinal cryosections were cut using a CM1950 cryostat (Leica Biosystems) 
such that 3-5 sections approximately 300µm apart were placed on one slide. 
 
Immunostaining. Sections were rehydrated in PBS and then permeabilized/blocked in 
0.3% TritonX-100, 1% BSA, 10% donkey serum (Jackson ImmunoResearch), and MOM 
blocking reagent (Vector Laboratories) for 1hr at room temperature. Slides were then 
incubated in primary antibodies [Anti-Synapsin-1 (5297S, Cell Signaling), anti-β-Tubulin 
III (T8578, Sigma-Aldrich), anti-S100 (RB044A0, Thermo Scientific Lab Vision), anti-
Myelin Basic Protein (AB9348, EMD Millipore)] in 0.3% Triton, 1% BSA overnight at 
4°C. The following day sections were washed in PBS and stained with fluorescently-
conjugated α-bungarotoxin and/or appropriate secondary antibodies (Biotium) in 0.3% 
Triton for one hour at room temperature. After final PBS washes, slides were 
coverslipped with DAPI mounting medium (Southern Biotech) and imaged on a confocal 




Reinnervation Analysis. Endplates identified by bungarotoxin staining were imaged at 
20x magnification with high resolution (2048x2048) and a z-step size of 1.5µm. Every 
endplate on one slide containing 3-5 sections was imaged. Maximum projection (LAS 
Software, Leica Biosystems) was applied to all files and every in-plane NMJ was scored 
from 0-5 to reflect its innervation status. Two markers were used for innervation scores: 
1) β-Tubulin III to reflect nerve reinnervation and 2) synapsin to reflect presynaptic 
differentiation. All imaging and scoring was performed by a single blinded observer that 
was unaware of the strain, genotype, and time point being analyzed. 
 
Statistical Analysis. 
All statistical analyses were performed using Prism 7 software (GraphPad). One- or 
two-way ANOVA was used for all analyses. Significant differences among pairwise 
comparisons were identified by Tukey’s or Sidek’s post hoc tests (Table 2). All graphs 
and error bars represent the mean ± standard error (se). 
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Gene Forward Primer (5’ – 3’) Reverse Primer (5’ – 3’) BP Source 
B2M TTCTGGTGCTTGTCTCACTGA CAGTATGTTCGGCTTCCCATTC 104 Tan et al., 2011 
Npn1 GAGGACAGAGACTGCAAGTATG CTGAAGACACCACAGGAGAAG 115 Primer3 
Sema3A ATATGCAAGAATGACTTTGGTGGAC AAGGAACACCCTTCTTACATCACTC 258 Primer3 
GAP43 ATAACTCCCCGTCCTCCAAGG GTTTGGCTTCGTCTACAGCGT 201 Harvard PrimerBank 
MuSK CCTCAGCCCGAGATTTCTTGG GTCTTCCACGCTCAGAATGGT 111 Harvard PrimerBank 
P0 CATCTCTTTTACCTGGCGCTAC TGTAAGGTTGTCCCTTGGCATA 83 Harvard PrimerBank 
S100 CTTCCTGGAGGAAATCAAGGAG CTCATGTTCAAAGAACTCATGGC 148 Primer3 
PlexinA1 GAGTGCAAGGAAGCTTTTGC TCCTCAATCCCAGGAAACAG 131 Fukuda et al., 2013 
PlexinA2 TATAACTGCAGTGCCCACCA TGGGGACAGTCCTCTGAAAC 149 Primer3 
PlexinA3 AGCATTCTGTGGTTTTCATCG CACCTGCTTCTCACTCAGGA 179 Primer3 
PlexinA4 ATCTAGAGTGGCGACAAGGAAG TGGAGACAGTGGAGTTGTTCAC 189 Fukuda et al., 2013 
MYH1 CTCTTCCCGCTTTGGTAAGTT CAGGAGCATTTCGATTAGATCCG 187 Harvard Primer Bank 
MYH2 ACTTTGGCACTACGGGGAAAC CAGCAGCATTTCGATCAGCTC 155 Harvard Primer Bank 
MYH3 CCAAAACCTACTGCTTTGTGGT GGGTGGGTTCATGGCATACA 149 Harvard Primer Bank 
MYH4 CTTTGCTTACGTCAGTCAAGGT AGCGCCTGTGAGCTTGTAAA 139 Harvard Primer Bank 
MYH6 TGCACTACGGAAACATGAAGTT CGATGGAATAGTACACTTGCTGT 204 Harvard Primer Bank 
MYH7 GCTACGCTTCCTGGATGATCT CCTCTTAGTGTTGACAGTCTTCC 248 Harvard Primer Bank 
 
 







Figure 2.1. Characterization of the common peroneal crush methodology. 
A, Graphical depiction of the experimental paradigm. A common peroneal nerve crush and contralateral sham 
operation were performed at day 0 (D0). Denervated (Den) and sham EDLs were collected at various time points 
following injury (n = 3 for all time points except D30, n = 2). B, Representative whole mount immunofluorescent 
images of sham (left) and D2 denervated (right) EDL sections fromThy1-YFP mice demonstrate a total loss of nerve 
innervation following the common peroneal nerve crush. Scale bar represents 250µm. C, Myelination at the D4 time 
point following nerve crush was examined by immunofluorescent staining. βIII-tubulin and acetylcholine receptors 
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stained with bungarotoxin (BTX) are shown in green, while the myelin markers S100 calcium binding protein B 
(S100b) and myelin basic protein (MBP) are shown in blue and magenta, respectively. Scale bar represents 50 µm. 
D, Representative images illustrate the scoring system (0-5) used to quantify NMJ reinnervation. BTX marks the 
endplate (magenta), βIII-Tubulin allows for visualization of the motor nerve (green), and synapsin stains the 
presynaptic nerve terminal (blue). E, The total number of neuromuscular junctions (NMJs) analyzed per animal was 
consistent across all time points analyzed (n.s., one-way ANOVA). F-G, Reinnervation was analyzed over the 30 day 
time course and the percent of NMJs scored as 0-5 is shown. Scoring was performed based on both nerve βIII-









Figure 2.2. Sema3A and its receptor components are expressed in skeletal muscle and spinal cord. 
Quantitative real-time PCR (qRT-PCR) was performed on RNA isolated from the gastrocnemius/plantaris (GP), 
extensor digitorium longus (EDL), soleus (Sol), and spinal cord (SC) tissues of C57BL/6J mice (n = 6). Individual 
gene expression was normalized to the β2-Microglobulin (B2M) housekeeping gene. Myosin heavy chain (MyHC) 
isoforms (A), Semaphorin3A (Sema3A, B), class A plexin family members (PlxA1-4, C), and neuropilin family 

































Figure 2.3. Sema3A and Npn1 gene expression decrease in the EDL after common nerve peroneal crush. 
A common peroneal nerve crush was performed and RNA was isolated at D7 (n = 9), D21 (n = 9), D30 (n = 4) and 
D50 (n = 4) from denervated and the contralateral control EDL muscles. In some cases, a nerve cut was performed 
instead of a nerve crush and tissues were collected at the D21 time point (n = 8). A-D, Gene expression for the 
postsynaptic gene Muscle-specific kinase (MuSK, A), the regeneration marker Growth-associated protein 43 (GAP-
43, B), and two myelin markers Myelin protein zero (MPZ, C) and S100 calcium binding protein B (S100B, D) were 
used as controls to demonstrate the effectiveness of the nerve crush and how the regenerative response changes 
over the examined time course. E-F, Gene expression for Neuropilin1 (Npn1, E) and Semaphorin3A (Sema3A, F) 
decrease in response to nerve crush injury. Npn1 levels return to baseline over the time course, while Sema3A 
remains low even at the latest time point examined. For all graphs, error bars represent the mean ± s.e and letters 











Figure 2.4. Loss of Npn1 modestly impairs NMJ reinnervation after injury. 
Graphical depiction of the experimental paradigm. Tamoxifen (TMX) was administered for 5 days, followed by a 10 
day rest period to allow for Cre-mediated recombination. At D0 a common peroneal crush was preformed and tissues 
were collected at the various time points. B, qRT-PCR was used to assess the level of Npn1 knockdown in GP 
muscle and SC from all mice used to examine reinnervation in subsequent experiments. The level of Npn1 transcript 
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detected in Npn1UBC mice (n = 21) is graphed relative to that observed in Npn1WT control littermates (n = 20) with the 
average percent knockdown in Npn1UBC mice displayed above the bar graph. C-D, Control or Npn1 
immunoprecipitation (IP), followed by immunoblotting for Npn1 was used to assess the amount of Npn1 protein in 
Npn1WT and Npn1UBC mice after TMX-mediated deletion. Representative western blots from the D30 time point 
demonstrate that Npn1UBC mice have no detectable levels of Npn1 protein in either the GP muscle (C) or the whole 
SC (D). Supernatants immunoblotted for alpha-tubulin (αTub) or actin are provided as loading controls. E, Npn1 
deletion does not alter the total number of scored NMJs observed at different time points after nerve crush injury 
(n.s., one-way ANOVA). F-G, The innervation status of sham-operated uninjured EDLs from Npn1UBC (n = 4) and 
Npn1WT (n = 4) mice was examined at the D21 time point. Scoring performed on the basis of nerve fiber (βIII-tubulin, 
F) or presynaptic terminal (synapsin, G) staining demonstrates that loss of Npn1 does not perturb the normal 
maintenance of the NMJ. H-K, Reinnervation following a nerve crush injury was examined in Npn1WT littermate 
controls (H,J) and Npn1UBC (I,K) mice. Innervation scores based on nerve βIII-tubulin staining (H,I) or presynaptic 
synapsin staining (J,K) produced similar trends. Despite loss of Npn1, early reinnervation (D7-D21) occurs normally. 
However, at D30, there appears to be a delay in motor nerve maturation as the number of NMJs scored as a ‘5’ are 
decreased. This effect is only transient as reinnervation is largely complete by the D50 time point. (L,M) 
Reinnervation data was replotted using only Scores 3-5 to directly compare differences between the two genotypes. 





























Figure 2.5. Loss of Sema3A does not impact NMJ reinnervation after injury. 
A, RNA was isolated from the GP muscle and SC of mice used for subsequent reinnervation studies. The level of 
Sema3A transcript detected in Sema3AUBC mice treated with corn oil (n = 10) or TMX (n = 12) is graphed relative to 
that observed in Sema3AWT control littermates (n = 12). The average percent knockdown in Sema3AUBC mice is 
displayed above each bar graph. B, GP muscle lysates were isolated from Sema3AWT and Sema3AUBC mice at 
various time points after nerve crush (D14-D30) and subjected to western blotting. No detectable Sema3A protein 
was observed after TMX-mediated deletion in Sema3AUBC mice. Supernatants immunoblotted for actin are provided 
as a loading control. C, Loss of Sema3A does not alter the number of NMJs scored at different time points (n.s., one-
way ANOVA). D-G, Reinnervation after a common peroneal crush was analyzed in Sema3AWT control littermates 
(D,F) and Sema3AUBC (E,G) mice. Innervation scores based on nerve βIII-tubulin staining (D,E) or presynaptic 
synapsin staining (F,G) followed similar trends. No differences in reinnervation were detected at any time point. (H,I) 
Reinnervation data was replotted using only Scores 3-5 to directly compare differences between the two genotypes. 




Figure 2.6. Npn1 deletion does not affect remyelination after a denervating injury. 
Myelination in sham injured and denervated EDLs was examined. The nerve and endplates were visualized by 
staining for βIII-tubulin and BTX (green), while the myelin was visualized by staining for S100b (blue) and MBP 
(magenta). A, Normal innervation and myelination is observed in sham injured EDL sections. B-C, At D7 after nerve 
crush there is a slight reduction in S100b and a near-total loss of MBP staining in both Npn1WT (B) and Npn1UBC (C) 








 Dysfunctions of the neuromuscular system such as spinal muscular atrophy 
(SMA) and amyotrophic lateral sclerosis (ALS) have complex disease etiologies. Recent 
evidence suggests that deficient RNA processing and trafficking may be a common 
mechanism underlying disease pathogenesis. Although problems associated with RNA 
metabolism can disrupt many different cellular processes, its impacts on local 
translation has gained increasing attention. Over the past 20 years, local translation in 
specialized compartments, such as axons, has become increasingly appreciated as a 
mechanism whereby proteins can be generated in a spatially and temporarily restricted 
manner. 
 To better understand the repertoire of mRNA transcripts utilized by motor 
neurons in vivo, we have utilized the RiboTag transgenic mouse model developed by 
Sanz et al., 2009 to specifically isolate ribosomal complexes and their associated 
mRNA transcripts. In this model, an HA epitope tag is encoded onto Ribosomal protein 
RPL22 (RPL22) in a Cre-recombinase (Cre) dependent manner. As a core member of 
the ribosome particle, RPL22HA is incorporated into the ribosome complex such that the 




 Here, motor neuron specific RPL22HA expression was achieved by crossing the 
RiboTag mouse line with Choline acetyltransferase (ChAT)-Cre mice. As expected, 
RiboTag;ChAT-Cre mice exhibited strong HA+ immunoreactivity in motor neuron cell 
bodies, while immunoprecipitation of ribosomal complexes led to the enrichment of 
motor neuron specific transcripts. Next, we used the RiboTag model to examine local 
translation in motor axons. Although we could detect a low level of background 
RPL22HA expression in Cre-negative mice, there was a significant Cre-dependent 
increase in RPL22HA protein and associated RNA in motor axons that innervate the 
skeletal muscle. While this caveat made it more challenging to purify motor axon 
specific ribosomal complexes, we were able to identify genes enriched within the axonal 
compartment by RNA-Seq. Finally, application of this technology to models of sciatic 
nerve crush and neurodegeneration in ALS highlight how it can be used to interrogate 
motor neuron specific changes in gene expression. Taken together, this research 
demonstrates how future use of this model can lead to unique insights into how motor 
neurons respond to a changing environment.  
 
Introduction 
Traditional methods commonly used to investigate cell type specific changes in 
gene expression include in situ hybridization, laser capture microdissection (LCM), and 
enzymatic dissociation followed by fluorescence-activated cell sorting (FACS). Although 
these methodologies have provided important insights into gene regulation, there are 
limitations associated with their usefulness to assess gene expression in complex 
tissues (Jung and Jung, 2016). While in situ hybridization allows for the careful 
assessment of RNA localization, it is not amenable to high-throughput profiling to 
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identify novel transcripts and it is less quantitative than other methods. Conversely, 
LCM and FACS sorting can be used on a broader scale for gene discovery, but each of 
these techniques come with their own challenges. Contamination by the proximity of 
adjacent cells can occur with LCM and the enzymatic dissociation process required for 
FACS purification can alter gene expression profiles. Additionally, an added challenge 
posed by FACS purification of certain neuronal populations is that axotomy combined 
with the stress of cell sorting often greatly reduces cell survival. Finally, and perhaps 
most importantly, the transcript numbers for many genes are uncorrelated with protein 
expression or are translated in a subcellular domain specific manner. These combined 
limitations create a ceiling for understanding the impacts of gene expression in specific 
populations and within subcellular compartments. 
To overcome these challenges, methods were developed to allow for the 
purification of ribosomal complexes from specific cell types. Translating Ribosome 
Affinity-Purification (TRAP) relies on genetic mouse models to introduce an epitope tag 
such as enhanced green fluorescent protein (eGFP) or hemagglutinin (HA) onto a 
ribosomal protein. When coupled with cell-type specific Cre-recombinase (Cre) 
expression, this provides a way to target specific cell populations (Heiman et al., 2008; 
Sanz et al., 2009; Jung and Jung, 2016). An antibody against the epitope tag can be 
used to immunoprecipitate tagged ribosomal complexes from whole tissues, thereby 
allowing for the isolation of actively translating mRNA transcripts. These purified RNAs 
can then be subjected to a wide array of downstream analyses.  
Here, we used RiboTag TRAP mice to explore motor neuron-specific gene 
translation in vivo. In this model, ribosomal protein L22 (RPL22) is genetically modified 
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to express RPL22-HA (RPL22HA) protein in a Cre-dependent manner (Sanz et al., 
2009). As a member of the 60S ribosomal subunit, RPL22HA is then incorporated into 
actively translating ribosomal complexes and can be immunoprecipitated with an HA 
antibody. To restrict RPL22HA expression to spinal motor neurons, the RiboTag mouse 
line was crossed with mice that express Cre under the Choline acetyltransferase 
(ChAT) promoter (Rossi et al., 2011). 
In characterizing this model, we were able to confirm that RiboTag;ChAT-Cre 
mice exhibit strong HA immunoreactivity in spinal motor neurons. Furthermore, we 
demonstrate that high-quality, motor neuron-specific mRNA transcripts can be isolated 
from HA-tagged ribosomes immunoprecipitated from spinal tissue. In addition to 
analyzing transcript expression from cell bodies in the spinal cord, we also asked 
whether this model could be used to examine local translation in motor axon terminals. 
Over the past decade this has emerged as a key regulatory mechanism used by a wide 
variety of neurons to rapidly respond to a diverse array of environmental signals (Kar et 
al., 2017). Although we found there is a low level RPL22HA expression in control mice, 
there is a clear ChAT-Cre dependent increase in RPL22HA protein and associated 
mRNA isolated from distal motor axons. 
Altogether, this work demonstrates the feasibility of using this methodology for 
novel gene discovery and as a system to investigate how motor neurons respond to 
injury and neurodegeneration. As such, our data strongly suggests that this technology 
can be used as a powerful tool to gain a better insight into how motor neurons respond 





As the interface between the motor and skeletal muscle systems, the 
neuromuscular junction (NMJ) is principally responsible for the ability of organisms to 
orchestrate body movements. In this system, somatic motor neuron cell bodies located 
in the ventral horn of the spinal cord integrate higher-order information and, upon 
activation, send an action potential down the motor axon that ultimately is translated into 
muscle contraction. To examine somatic motor neuron gene expression, we crossed 
RiboTag homozygous mice (RiboHO) to the ChAT-Cre mouse line. ChAT is an enzyme 
necessary for the production of acetylcholine (ACh), the principle neurotransmitter 
utilized by somatic motor neurons. Therefore, we expected this strategy to drive strong 
RPL22HA expression in all cholinergic neurons, including motor neurons. 
Spinal cords from mice heterozygous for the RiboTag allele and either ChAT-
Cre+ or ChAT-CreWT (RiboHET;ChAT+ and RiboHET;ChATWT) were isolated and stained 
with various markers to characterize RPL22HA expression (Figs. 3.1 to 3.3). First, four 
major populations of RPL22HA cells were identified by staining RiboHET;ChAT+ spinal 
cord sections with HA (red), the neuronal marker NeuN (Green), and ChAT (blue). As 
expected, NeuN+ChAT+ somatic motor neurons in the ventral horn were clearly 
observed to be HA+ (Fig. 3.1E). Additionally, two other cholinergic populations were 
identified through RPL22HA expression. HA+ pre-motor interneurons, previously 
described to play a neuromodulatory role during locomotive behavior (Zagoraiou et al., 
2009), were found around the central canal (Fig. 3.1B), while HA+ preganglionic visceral 
motor neurons that project axons to sympathetic ganglia of the autonomic nervous 
system (Stifani, 2014) were found in the lateral horn (Fig. 3.1C). Finally, we also 
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observed an unexpected but rare population of HA+NeuN+ChAT- cells in the ventral horn 
of the spinal cord (Fig. 3.1D). Although the origin and function of these cells is unclear, 
we believe they might represent a population of interneurons that were cholinergic at 
some point during development, but have since stopped producing acetylcholine. 
Next, we set out to more thoroughly examine RPL22HA expression in somatic 
motor neurons. Similarly to that described above, spinal cord sections from 
RiboHET;ChATWT (Fig. 3.2A-D) and RiboHET;ChAT+ (Fig. 3.2E-H) mice were stained with 
HA (red), the neuronal marker NeuN (Green), and ChAT (blue). Representative spinal 
cord hemisections demonstrate that both RiboHET;ChAT+ and control littermates exhibit 
strong ChAT+ staining in the ventral horn; however, RPL22HA expression is only 
observed in RiboHET;ChAT+ mice (Fig. 3.2G vs. Fig. 3.2C). 
Somatic motor neurons can further be classified into two main populations. Alpha 
motor neurons (αMNs) innervate extrafusal muscle fibers at the NMJ and are therefore 
responsible for the initiation of muscle contraction, while gamma motor neurons (γMNs) 
innervate intrafusal muscle fibers at the muscle spindle and are necessary for 
proprioceptive feedback as the muscle is stretched during contraction (Hulliger, 1984). 
Interestingly, these two populations can be readily distinguished from each other by size 
and NeuN expression (Friese et al., 2009). More specifically, αMNs are NeuN+ChAT+ 
and have larger somal diameters (Fig. 3.2I-L, arrowhead), while γMNs are NeuN-ChAT+ 
and exhibit smaller somal diameters (Fig. 3.2I-L, asterisk). To quantify the relative 
proportion of RPL22HA expression in RiboHET;ChATWT and RiboHET;ChAT+ mice, serial 
sections through the lumbar spinal cord were analyzed. Overall, mice of both genotypes 
contained a similar percentage of αMNs (~80%) and γMNs (~20%) in the ventral horn of 
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the spinal cord. Importantly, while almost every motor neuron from RiboHET;ChAT+ mice 
were HA+, very few cells (αMNs 2.55 ± 0.722, γMNs: 0.59 ± 0.304) were marked as HA-. 
Additionally, no inappropriate HA expression was observed in any of the RiboHET;ChAT- 
mice (Fig. 3.2M). 
Lastly, we co-stained spinal cord sections for RPL22HA (HA antibody, red) and 
either glial fibrillary acidic protein (GFAP, blue, Fig. 3.3A-C) or microtubule-associated 
protein 2 (MAP2, green, Fig. 3.3D-F). Through the use of these two staining schemes, 
the absence of RPL22HA staining can be appreciated in GFAP+ oligodendrocytes, while 
positive RPL22HA staining can be observed extending into MAP2+ motor neuron 
dendrites (see arrowheads). 
 
Immunoprecipitation and Isolation of Motor Neuron Specific mRNA Transcripts. 
 After immunohistochemical characterization of RPL22HA localization in motor 
neuron cell bodies, we next sought to examine if RPL22HA protein could be detected 
after immunoprecipitation from spinal tissue. Whole spinal cords were collected from 
RiboTagHO;ChAT+ (RiboHO;ChAT+), RiboHet;ChAT+, and various wild-type (WT) mice of 
different genotypes (C57BL6, RiboTagWT;ChAT-Cre+; RiboTagHet;ChATWT; 
RiboTagHO;ChATWT). Since all control groups behaved similarly, the results were 
averaged and displayed as one WT group. Western blotting following HA 
immunoprecipitation was then used to examine RPL22HA expression. The 
representative western blot (Fig. 3.4A) demonstrates that RPL22HA protein is expressed 
in spinal cord lysates at a level that can be detected in whole cell lysates (WCL) prior to 
HA immunoprecipitation. HA immunoprecipitation greatly enhances the amount of 
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detected RPL22HA protein in the immunoprecipitated product (IP), while simultaneously 
depleting the levels observed in the supernatant (SUP). In addition to HA, the amount of 
actin detected in the supernatant was also determined and used as a loading control for 
each sample (Fig. 3.4B). Finally, for all experiments the amount of HA detected in the IP 
was quantified and normalized to the amount of supernatant actin. Overall, a significant 
and gene dose-dependent increase in HA protein can be appreciated among the 
various genotypes (WT, 1.00 ± 0.594; RiboHet;ChAT+, 19.97 ± 4.826; RiboHO;ChAT+, 
36.85 ± 6.56) (Fig. 3.4C). 
 With evidence of successful RPL22HA protein isolation, we next examined 
whether RNA could be obtained from isolated ribosomal complexes. Spinal cords from 
WT, RiboHet;ChAT+, and RiboHO;ChAT+ mice were lysed, immunoprecipitated with an 
HA antibody, and associated RNAs were purified. Isolated RNA was then analyzed by a 
Bioanalyzer to determine RNA quality (Fig. 3.5A) and concentration (Fig. 3.5B). High 
quality and intact RNA was routinely isolated from all mice analyzed (average RIN 
values for WT, 8.26 ± 0.661; RiboHet;ChAT+, 9.10 ± 0.280; RiboHO;ChAT+, 8.18 ± 0.282). 
Furthermore, similar to RPL22HA protein, we observed a gene dose-dependent amount 
of RNA was isolated from immunoprecipitated ribosomes (WT, 2.24 ± 0.442; 
RiboHet;ChAT+, 17.09 ± 6.658; RiboHO;ChAT+, 49.15 ± 3.398). 
 Next, we sought to validate that immunoprecipitated RNA contained transcripts 
that are specific to motor neurons. To do this, RT-qPCR was used to assess the 
expression of positive and negative control genes expected to be enriched or absent in 
the IP. ChAT expression was used as the positive control, while the interneuron marker 
calbindin and the oligodendrocyte marker 2’3’-cyclic-nucleotide 3’-phosphodiesterase 
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(CNPase) were used as negative controls (Lappe-Siefke et al., 2003; Merkulyeva et al., 
2015). Expression data was then analyzed and displayed using two different analyses. 
The percent input (Fig. 3.5C) shows the expression of each gene in the IP as a 
percentage of that observed in the input. Interestingly, both RiboHet;ChAT+ and 
RiboHO;ChAT+ showed a similar level ChAT enrichment after RPL22HA IP (23.62 ± 5.147 
vs. 22.9725 ± 2.738, respectively), although RiboHet;ChAT+ mice exhibited a higher 
degree of variability. Furthermore, no enrichment of either calbindin or CNPase 
transcript was observed in mice of any genotype. In addition to percent input analysis, 
RT-qPCR data was also graphed as the fold enrichment of transcript detected in 
RiboTag+ChAT+ mice (RiboHet;ChAT+ and RiboHO;ChAT+ samples are averaged into one 
group) over that observed in WT mice. Accordingly, no enrichment was observed in the 
input sample for any gene examined, while a dramatic upregulation of ChAT transcript 
(117.88 ± 17.927) was observed in the IP (Fig. 3.5D). 
 Finally, after a preliminary validation that motor neuron specific mRNA transcripts 
could indeed be immunoprecipitated from whole spinal cords, we sought to perform a 
more in-depth analysis of region-specific gene expression. To this end, spinal cords 
were isolated from RiboTagHO;ChAT+ and RiboTagHO;ChATWT (RiboHO) littermates and 
dissected into cervical (SC-C), thoracic (SC-T), and lumbar (SC-L) regions. HA 
immunoprecipitations were then performed from each region separately and purified 
RNA was subjected to Bioanalyzer analysis and RT-qPCR. Genes were selected for 
analysis based on previously reported patterns of region-specific expression. The 
experimental paradigm is diagramed in Fig. 3.6A, with the cervical (yellow), thoracic 
(blue), and lumbar (orange) regions separated into segments. The colored bars in the 
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schematic represent the approximate location of the different motor columns 
interrogated for various gene expression patterns. Importantly, Bioanalyzer analysis 
revealed that the amount of total RNA isolated in the WCLs of RiboHO controls and 
RiboHO;ChAT+ mice was similar for all spinal cord regions examined (Fig. 3.6B). 
Furthermore, following the IP, significantly more RNA was isolated from RiboHO;ChAT+ 
mice (SC-C, 357.38 ± 30.734, SC-T, 117.71 ± 26.796, SC-L, 377.38 ± 19.915) than 
RiboHO littermates (SC-C, 12.51 ± 7.059, SC-T, 15.79 ± 8.373, SC-L, 23.39 ± 11.197) 
(Fig. 3.6C). Additionally, significantly less RNA was isolated from RiboHO;ChAT+ IPs 
isolated from the SC-T region compared to the SC-C (p = 0.0003) and SC-L (p < 
0.0001) regions, which was not surprising given that the cervical and lumbar segments 
contain enlargements to accommodate innervation of the limbs (Fig. 3.6C). 
 Gene expression enrichment in the IP compared to the average of the 
corresponding WCL sample for each region was then examined (Fig. 3.6D-M). The two 
negative control genes calbindin (Fig. 3.6D) and CNPase (Fig. 3.6E) demonstrate a 
highly significant de-enrichment of both transcripts in the IP compared to the WCL 
(calbindin, p ≤ 0.0001; CNPase, p < 0.001). Next, we looked at Islet1 (Isl1, Fig. 3.6G) 
and ChAT (Fig. 3.6G) gene expression in the different spinal cord regions. As genes 
known to be globally expressed in many motor column populations, we found a 
significant upregulation (>10 fold, p < 0.01) of both genes in the IP from each region 
compared to the corresponding WCLs. Other genes more specific to different motor 
columns were then examined for regional expression patterns. Activated leukocyte 
adhesion molecule (Alcam) is a gene previously shown to be expressed by motor 
neurons of the spinal accessory column (SAC), whose cell bodies originate in the 
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cervical spinal cord and axons extend out to innervate muscles of the head and neck 
(Dillon et al., 2005). Forkhead Box P1 (Foxp1) expression was chosen because it is well 
established as a maker of lateral motor column (LMC) motor neurons that innervate the 
fore- and hindlimbs (Dasen et al., 2008). Three other genes were selected for analysis 
because of their reported expression in the thoracic spinal cord. Homeobox C9 (HoxC9) 
and ETS variant 1 (ETV1) are reported markers of the hypaxial motor column (HMC) 
that innervates the axial muscles of the trunk, while Neuronal nitric oxide synthase 
(nNOS) has been found to be expressed by preganglionic visceral motor neurons that 
innervate sympathetic ganglia (Saito et al., 1994). Generally speaking, gene expression 
in the different regions of the spinal cord after RPL22HA IP matched what was reported 
in the literature. Specifically, we found Alcam expression was significantly elevated in 
the SC-C (SC-T IP, p = 0.0018, SC-L IP, p < 0.0001, WCLs, p = 0.0002), while no 
enrichment was observed in the other regions of the spinal cord (Fig. 3.6H). Similarly, 
other genes predicted to be expressed in the thoracic spinal cord showed specific 
increases in SC-T samples. HoxC9 (Fig. 3.6J) was significantly enriched in the SC-T IP 
compared to the SC-L IP (p = 0.0367) and the WCLs (p = 0.0127), while ETV1 (Fig. 
3.6K) showed significant enrichment compared to the SC-C IP (p = 0.0019) and the 
WCLs (p = 0.007). Additionally, there was also a trend towards increased expression of 
ETV1 in the SC-T IP compared to SC-L IP (p = 0.075). The same pattern was also seen 
for nNOS (Fig. 3.6L) expression, with enrichment only observed in the SC-T (SC-C IP, p 
= 0.003, SC-L IP, p = 0.0002, WCLs, p < 0.0001). The only gene that did not match the 
predicted pattern of expression was Foxp1, which showed no difference in the IP from 
any of the spinal cord regions (Fig. 3.6I). Although Foxp1 is a well-established marker 
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for LMC motor neurons during development (Dasen et al., 2008), it is possible that we 
did not observe any expression after RPL22HA IP because it is downregulated in adult 
motor neurons. Finally, the last gene we examined was Paired-like homeodomain 
transcription factor 2 (Pitx2). Pitx2 has been characterized as a specific marker for the 
pre-motor cholinergic interneurons that reside near the central canal at all regions of the 
spinal cord (see Fig. 3.1B) (Zagoraiou et al., 2009). As expected, we observed a 
significant enrichment of Pitx2 gene expression in all regions examined compared to the 
corresponding WCLs, with the highest level of expression observed in the SC-T (SC-C 
IP, p = 0.070; SC-L IP, p = 0.0008; WCLs, p < 0.0001). Taken together, our data 
demonstrate that this RiboTag methodology can be used not only to isolate spinal motor 
neuron specific mRNA transcripts in vivo, but can also be used for the regional analysis 
of specific motor columns.  
 
Isolation of Motor Neuron Specific Ribosomal Complexes from Motor Axons. 
 Over the past 20 years there has been an increasing appreciation for the role of 
local translation in many different cell types (Willis and Twiss, 2010). This has been 
found to be especially true in neurons, which have highly complex cellular morphologies 
including extensive dendritic arborization and axons that project long distances from the 
cell body. The ability to regulate mRNA localization and translation provides an efficient 
mechanism by which proteins can be produced in a spatially and/or temporally 
restricted manner. We now have overwhelming evidence that many types of neurons 
use local protein translation in dendrites (Sutton and Schuman, 2006). Additionally, 
while it was originally suggested that local translation does not occur in axons, recent 
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studies have identified translational machinery in axons (Gonzalez et al., 2016) and 
transcriptome-wide axonal profiling has identified an abundance of mRNA in axons 
(Deglincerti and Jaffrey, 2012). While the degree of local translation in motor neuron 
axons has not been examined in vivo, several studies have observed local translation in 
motor axons using in vitro systems (Briese et al., 2016; Fallini et al., 2016). 
 The RiboTag;ChAT-Cre mouse model offers a unique opportunity to examine 
local translation in motor axons. First, the physical distance between motor neuron cell 
bodies in the spinal cord and distal axons innervating skeletal muscle allows for the 
isolation of mRNA transcripts from distinct locations. Second, ChAT expression within 
skeletal muscle is restricted to cholinergic motor neuron innervation. To examine this 
more closely, the ChAT-Cre mouse line was crossed into the R26/CAGmTmG reporter 
line. In the resulting mice, in the absence of Cre, all cells ubiquitously express 
tdTomato. However, exposure to Cre under the ChAT promoter results in a switch from 
tdTomato to enhanced green fluorescent protein (eGFP) expression (Fig. 3.7A). 
Skeletal muscles from these mice were isolated and stained to identify where GFP-
reporter expression is localized. As expected, ßIII-tubulin+ nerve fibers innervating 
motor endplates labeled by bungarotoxin (BTX) demonstrated strong colocalization with 
GFP staining (Fig. 3.7B). In contrast, sympathethic nerves that follow blood vessels are 
clearly labeled by ßIII-tubulin but have no detectable level of GFP staining (Fig. 3.7C, 
arrowheads). In addition to characterization with reporter mice, RT-qPCR analysis of 
total RNA isolated from C57BL/6 wild-type skeletal muscle did not detect ChAT 
transcript (CT values ranging from 38 to undetectable, data not shown). Taken together, 
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these data suggest that motor axons are the only source of RPL22HA detected in 
muscles of the RiboTag;ChAT-Cre model. 
 To examine local translation in motor axons, quadriceps (Quad) or 
gastrocnemius/plantaris (GP) skeletal muscle was isolated from WT mice of various 
genotypes (as described previously for spinal cord isolations in Fig. 3.4), RiboHet;ChAT+, 
and RiboHO;ChAT+ mice. Individual muscles were lysed and subjected to HA 
immunoprecipitation followed by immunoblotting for RPL22HA protein. The 
representative western blot (Fig. 3.8A) demonstrates that while HA protein can be 
detected in skeletal muscle, there is an apparent leakiness in RiboTagHet;ChATWT and 
RiboTagHO;ChATWT (RiboTag+) control mice. Importantly, C57BL/6 WT mice and 
RiboWT;ChAT+ contols (RiboWT) controls show no HA expression, even under the 
longest exposures. Furthermore, there is an observable ChAT-Cre dependent increase 
in the amount of RPL22HA detected after immunoprecipitation in two of the three 
RiboHO;ChAT+ mice. To quantify results across multiple experiments, the amount of 
RPL22HA protein in the IP was then normalized to the amount of α-tubulin (αTub) in the 
corresponding supernatant. Although there is a degree of variability in the amount of 
RPL22HA present in motor axons innervating the Quad (Fig. 3.8B) and GP (Fig. 3.8C) 
muscles, there is a specific and significant increase in RiboHO;ChAT+ mice compared to 
the other genotypes examined. 
 Next, we asked whether associated RNA could be isolated from RPL22HA tagged 
ribosomal complexes from motor axons innervating muscle tissue. Similar to that 
described above, RNA was purified after HA immunoprecipitation and subjected to 
Bioanalyzer analysis. Although RIN values were slightly reduced compared to what was 
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observed in the spinal cord (Fig. 3.5A), high quality RNA was routinely isolated from all 
genotypes examined (Ribo+, 7.44 ± 0.556; RiboHET;ChAT+, 7.314 ± 0.503; 
RiboHO;ChAT+, 7.36 ± 0.260, Fig. 3.9A). Additionally, differentiating between the two 
different control groups (RiboWT and Ribo+) revealed that there were significantly lower 
RIN values observed in the absence of the RiboTag allele.  
 Finally, similar to that observed for RPL22HA protein isolated from motor axons, 
the amount of RNA enriched by immunoprecipitation was only apparent in 
RiboHO;ChAT+ mice. The amount of isolated RNA across various experiments was 
analyzed as the raw concentration given by the Bioanalyzer (Fig. 3.9B) and as the fold 
enrichment of RNA in RiboHET;ChAT+ and RiboHO;ChAT+ mice over WT samples run on 
the same day (Fig. 3.9C). Graphing the fold enrichment helps to control for trial to trial 
variability in the amount of RNA associated with control IPs and demonstrates there is 
indeed a significant enrichment of RNA associated with isolated ribosomal complexes in 
RiboHO;ChAT+ mice. 
 
Novel Gene Discovery from Motor Neuron Cell Bodies and Axons 
 We next wanted to determine whether RNA sequencing (RNA-Seq) could be 
performed on RNA isolated from RPL22HA immunoprecipitated ribosomes to identify 
novel transcripts produced by motor neuron cell bodies and/or axons. To this end, RNA 
associated with ribosomal complexes was isolated from RiboHO and RiboHO;ChAT+ 
spinal cord or muscle tissues (Fig. 3.10A). After limited rounds of cDNA amplification, 
sequencing was performed using the Illumina Hi-Seq platform. Raw sequencing data 
then underwent alignment and differential expression analysis. HTSeq Count 
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Assignments and Star Alignment Scores were used to demonstrate that samples 
contained good quality reads that aligned to the reference sequence (data not shown). 
For differential gene expression analysis, conditions were set to remove genes with less 
than 10 read counts in all conditions. Next, limits on the adjusted p-value (<0.01), false 
discover rate (<0.01), and log2FoldChange (>2) were imposed. Differential gene 
expression comparing 100 transcripts found after HA IP in the RiboHO;ChAT+ group (IP) 
and the RiboHO group (Ctl IP) are displayed in the heat maps (Fig. 3.10B-C). In addition 
to IP samples, WCL RNA was isolated before the HA immunoprecipitation and was also 
used as a control group. Heat maps comparing transcripts isolated from cell bodies in 
the spinal cord (SC, Fig. 3.10B) and axons from the GP muscle (Fig. 3.10C) illustrate a 
hierarchical clustering among sample types, with the IP and WCL appearing more 
similar to one another than to the Ctl IP. Additionally, in samples isolated from the SC, 
there is a clear enrichment of genes expressed in the IP (dark blue) that are not 
observed in the Ctl IP (light green). Furthermore, while some genes enriched in the IP 
are detected at lower levels in the WCL, there is also evidence that RPL22HA 
immunoprecipitation allowed for the detection of motor neuron specific transcripts that 
were not observed in the WCL (see black bar in Fig. 3.10B). While patterns of 
enrichment in transcripts isolated from the GP muscle (Fig. 3.10C) are not as dramatic 
in the heat map, volcano plots were also used to examine enrichment in the IP versus 
the Ctl IP (Fig. 3.11A-B). In analysis from the SC (Fig. 3.11A) and GP (Fig. 3.11B), 
genes enriched in the Ctl IP have a negative log2FoldChange (skewed to the left), while 
genes enriched in the IP have a positive log2Fold Change (skewed to the right). 
Importantly, more transcripts with lower p-values (more significant) were observed 
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skewing to the right, indicating that the IPs from both tissue types were enriched relative 
to that observed in the Ctl IPs. Lastly, the total number of genes found to be enriched in 
motor neuron cell bodies verses axons was compared. Overall, 1066 genes were found 
to be specific to motor neurons in the spinal cord, while 114 axonally located genes 
were identified from the muscle (Fig. 3.11C). Of the two groups of transcripts identified, 
24 were found to be expressed by both compartments. 
 After differential gene expression, gene ontology (GO) and Kyoto Encyclopedia 
of Genes and Genomes (KEGG) analyses were performed to further characterize genes 
expressed by motor neuron cell bodies and axons. First, transcripts enriched in motor 
neuron cell bodies over the Ctl IP were analyzed. GO enrichment analysis (Fig. 3.12) 
demonstrates that many of the overrepresented categories belong to metabolic 
processes, while axon development and axonogenesis were also represented. KEGG 
pathways analysis was also performed to show higher-order relationships (Fig. 3.13A-
B). The top represented pathways are displayed by significance (Fig. 3.13A) and 
relationally to one another in a network diagram (Fig. 3.11B). Interestingly, genes 
associated with oxidative phosphorylation and with different forms of neurodegeneration 
(Huntington’s, Parkinson’s, and Alzheimer’s disease) were over represented within the 
data set. Furthermore, the relational analysis demonstrates that each of those 
categories are directly interrelated with each other. Taken together, the GO enrichment 
and KEGG pathways analyses highlight metabolic processes as one the core biological 
pathways integral to proper motor neuron function. Additionally, the finding that motor 
neuron specific genes are associated with various forms of neurodegenerative disease 
is also intriguing as pathogenesis in motor neuron diseases such as amyotrophic lateral 
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sclerosis (ALS) has been linked to oxidative stress and mitochondrial damage (Sas et 
al., 2007; Johri and Beal, 2012). 
 Next, the KEGG pathways analysis was performed on transcripts identified from 
motor neuron cell bodies versus axons. This relational analysis identified significantly 
overrepresented pathways from both data sets, where genes enriched in cell bodies are 
shown in green and axonally localized genes are shown in red (Fig. 3.14). Similar to 
that observed in motor neuron cell bodies alone, oxidative phosphorylation and various 
neurodegenerative pathways were found to be overrepresented. However, comparing 
genes between the cell body and axonal compartments also led to the identification of 
other KEGG categories including the synaptic vesicle cycle, cholinergic synapse, and 
various signaling pathways. Furthermore, from this analysis cell bodies were observed 
to express many genes known to be expressed by motor neurons (i.e. the cholinergic 
markers ChAT and VAChT (Slc18a3) and neurofilament proteins like Nefm, Prph, Nefh 
and Nefl). Finally, some genes specific to the axonal compartment were also identified, 
including Dynein axonemal intermediate chain 1 (Dnaic1), Wnt7b, a voltage-gated 
potassium channel (Kcnq3), the opioid receptor Oprm1, and a gene associated with the 
cytoskeleton Profilin 4 (Pfn4). Importantly, future localization studies will be required to 
explicitly determine whether these are indeed locally translated in motor axons.  
 
Applying the RiboTag Technology to Investigate How Motor Neurons Respond to 
Injury and Disease. 
 After demonstrating that this RiboTag methodology can be applied to investigate 
motor neuron specific gene expression, we next asked whether it was sensitive enough 
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to detect changes associated with either an acute injury or in chronic 
neurodegeneration. First, a sciatic nerve crush model was used to examine if an acute 
trauma could trigger detectable gene expression changes in spinal motor neuron cell 
bodies. To this end, the sciatic nerve of RiboHO control littermates and RiboHO;ChAT+ 
mice were crushed at the mid-thigh level, while the contralateral leg was left uninjured 
(UNI). The lower 2/3 of the lumbar spinal cord was then isolated 7 days (D7) after the 
nerve crush and the injured and contralateral uninjured hemispheres were separated. 
D7 and UNI lumbar cords were then processed for RPL22HA IP separately and the 
isolated RNA was analyzed by Bioanalyzer and RT-qPCR. Like that observed in our 
earlier experiments, a similar amount of total RNA was isolated from UNI and D7 spinal 
cord WCLs regardless of genotype (Fig. 3.15A). Furthermore, RPL22HA IP only resulted 
in the isolation of an appreciable amount of RNA from RiboHO;ChAT+ mice but not 
RiboHO controls (p < 0.01, Fig. 3.15B). Next, RT-qPCR was used to analyze how various 
genes changed in the WCL (left column, Fig. 3.15C,E,G,I) or after IP enrichment (right 
column, Fig. 3.15D,F,H,J). Interestingly, apart from the p75 neurotrophin receptor (P75, 
Fig. 3.15G), no injury-induced changes in gene expression could be detected in the 
WCL 7 days after nerve crush. However, the enrichment of motor neuron specific 
transcripts following RPL22HA IP allowed for the sensitive detection of injury induced 
changes in gene expression. More specifically, a significant reduction in ChAT transcript 
was detected at the D7 time point compared to the UNI control (p = 0.0038, Fig. 3.15D), 
while GAP43 (Fig. 3.15F), P75 (Fig. 3.15H), and brain derived neurotrophic factor 
(BDNF, Fig. 3.15J) were all specifically increased at the D7 time point (GAP43, p = 
0.0001; P75, p = 0.0015; BDNF, p = 0.0016) in accordance with previously published 
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studies that used in situ hybridization (Chong et al., 1992; Hayes et al., 1992; Ikeda et 
al., 2001; De Winter et al., 2006; Meeker and Williams, 2014). 
 In addition to assessing injury-induced changes in motor neuron cell bodies, we 
also asked whether sciatic nerve crush injury could alter local translation in motor 
axons. Interestingly, in other neuronal cell types it has been widely appreciated that 
there is a low, basal level of local translation in uninjured axons that can be dramatically 
upregulated in response to injury (Twiss and Shooter, 1995; Willis and Twiss, 2010). To 
investigate changes in local translation after sciatic nerve crush we used RPL22HA 
protein expression as a readout for changes in translational activity. RiboHO controls and 
RiboHO;ChAT+ mice underwent a common peroneal nerve crush (see Chapter 2 for 
description of this injury model). Tibialis anterior (TA) muscles were collected at D7 after 
crush and RPL22HA IPs were performed from injured and UNI muscles. Supernatant 
(SUP) samples were immunoblotted for αTub and synapsin as a control (Fig. 3.16A). 
The expression of both proteins was found to be regulated by nerve crush injury, with 
injury resulting in increased αTub and decreased synapsin expression. Next, the 
amount of immunoprecipitated RPL22HA in RiboHO and RiboHO;ChAT+ was examined. 
Most uninjured TA muscles from RiboHO;ChAT+ showed little to no RPL22HA expression; 
however, at D7 after crush, the amount of RPL22HA protein detected in denervated TAs 
was dramatically upregulated compared to all other groups examined (Fig. 3.16B-C). 
Finally, in addition to assessing the amount of RPL22HA in the IP, we also asked if 
phospho-S6 Ribosomal Protein (p-S6) could be detected in the co-IP. Ribosomal 
protein S6 is a member of the 40S ribosomal subunit that is known to result in increased 
protein translation upon phosphorylation of key residues (Dufner and Thomas, 1999). 
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Interestingly, we found that p-S6 protein did indeed co-IP with RPL22HA after nerve 
crush injury (Fig. 3.16B). Taken together, these results indicate that RiboTag technology 
can be used to detect small changes in motor neurons in response to peripheral injury 
with high sensitivity. Furthermore, an injury-induced increase in RPL22HA expression, 
coupled with the observation that p-S6 is specifically observed in the co-IP, supports the 
notion that acute injuries result in an upregulation of local translation in motor axons.  
Finally, to examine how motor neuron gene expression changes in the context of 
neurodegenerative disease, the RiboTag;ChAT-Cre line was crossed into the SOD1G93A 
mouse model of ALS. The time course of disease progression in this model has been 
studied extensively in the past (Hegedus et al., 2007; Acevedo-Arozena et al., 2011). 
Briefly, young SOD1G93A mice are categorized as presymptomatic because there are no 
signs of muscle atrophy or motor neuron cell death, although early bouts of denervation 
can be detected at the NMJ. As mice approach 3 months of age, they enter a 
symptomatic disease phase in which chronic denervation leads to increased muscle 
wasting and motor neuron cell death. Ultimately, by 4.5 to 5 months of age, SOD1G93A 
mice reach a terminal phase in which they experience total hindlimb paralysis and 
eventual death.  
In crossing the SOD1G93A and RiboTag;ChAT-Cre mice, four genotypes were 
generated: SOD1G93A;RiboHO;ChAT+ (ALS RiboHO;ChAT+), SOD1WT;RiboHO;ChAT+ (WT 
RiboHO;ChAT+), SOD1G93A;RiboHO (ALS RiboHO), and SOD1WT;RiboHO (WT RiboHO). 
Mice were then aged to either an early symptomatic (P90) or terminal (P150) time point. 
While some of the work fully characterizing this line is ongoing, early studies 
investigating RNA isolation from motor neuron cell bodies illustrate the sensitivity of this 
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technique. First, lumbar spinal cords were lysed, RPL22HA was immunoprecipitated, and 
associated RNAs were isolated and subjected to Bioanalyzer analysis. At both time 
points, the specificity of the RPL22HA IP was demonstrated by the significant enrichment 
of RNA in ALS and WT RiboHO;ChAT+ mice compared to RiboHO controls (p < 0.01, Fig. 
3.17A-B). Interestingly, at the P90 early symptomatic time point we also observed a 
statistically significant increase in the amount of RNA isolated from ALS RiboHO;ChAT+ 
mice compared to WT RiboHO;ChAT+ controls (p = 0.04, Fig. 3.17A). Conversely, 
because extensive motor neuron cell death was expected at the terminal P150 time 
point, we hypothesized that ALS RiboHO;ChAT+ mice would have less isolated RNA 
following immunoprecipitation. However, in contrast to our hypothesis, no difference in 
the amount of RNA isolated was observed (Fig. 3.17B). 
Lastly, for the experiments described above, protein samples were also co-
purified from the WCL and IP samples that were processed for RNA. Isolated protein 
from ALS and WT mice was then examined for RPL22HA and p-S6 expression by 
immunoblotting. WCLs were analyzed for αTub and ChAT expression as loading 
controls (Fig. 3.18A-B). Additionally, HA expression in WCLs at the P90 (Fig. 3.18C) 
and the P150 (Fig. 3.18D) time points demonstrated that RPL22HA was only detected in 
RiboHO;ChAT+ mice and not RiboHO controls; however, there were no appreciable 
differences between ALS RiboHO;ChAT+ and WT RiboHO;ChAT+ mice. We also examined 
the levels of p-S6 in the WCL and the co-IP. While, p-S6 protein was detected in the 
WCLs of all mice at both time points (Fig. 3.18E-F), a dramatic increase in p-S6 protein 
was detected in ALS RiboHO;ChAT+ mice at the P90 time point (Fig. 3.18G) and almost 




 In this Chapter we characterized and validated the RiboTag;ChAT-Cre mouse 
model as a means of isolating spinal motor neuron specific ribosome-associated RNAs. 
As expected, we found that RPL22HA protein was produced in a ChAT-Cre dependent 
manner by spinal motor neurons (Figs. 3.1 to 3.2) and that it could be efficiently 
immunoprecipitated from whole spinal cord lysates with an HA antibody (Figs. 3.4). 
Additionally, after HA IP, high quality RNA could be isolated from immunoprecipitated 
ribosome complexes (Figs. 3.5A-B). Although RPL22HA protein and RNA could be 
isolated from RiboTagHet;ChAT+ and RiboTagHO;ChAT+ mice, we found that the total 
amount observed corresponded to genotype in a gene-dosage dependent manner. 
Furthermore, we used RT-qPCR to characterize the specificity of the mRNAs 
associated with the RPL22HA IP (Figs. 3.5 to 3.6). Using positive (ChAT) and negative 
(Calbindin and CNPase) control genes we demonstrated that there was indeed a 
significant enrichment of motor neuron specific genes after RPL22HA IP, but not in the 
WCL or RiboTagHO control littermates (Figs. 3.5C-D). Finally, taking advantage of the 
fact that populations of motor neurons within specific motor columns are characterized 
by different genes, we demonstrated that region specific gene expression patterns could 
be analyzed using this methodology (Figs. 3.6). 
 Cholinergic neuron populations in the spinal cord have been described in detail 
and are known to include pre-motor neurons (Figs. 3.1B) (Zagoraiou et al., 2009) and 
preganglionic visceral motor neurons (Figs. 3.1B) (Stifani, 2014) in addition to somatic 
motor neurons (Figs. 3.1E) that innervate skeletal muscle. Therefore, it is not a surprise 
the ChAT-Cre mouse line does not provide a pure analysis of somatic motor neuron 
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specific gene expression. Importantly, we selected the ChAT-Cre mouse line because it 
drives strong Cre expression in somatic motor neurons while excluding most 
interneuron populations. To date, other methods to target Cre expression in motor 
neurons have included using the Homeobox gene HB9 (Hb9) or Vesicular Acetylcholine 
Transporter (VAChT) promoters. Although Hb9-Cre mice have been extensively used in 
the past as a motor neuron specific Cre line, Hb9 is also involved in the specification of 
preganglionic visceral motor neurons (Arber et al., 1999) and more importantly is known 
to be expressed in a population of premotor glutamatergic interneurons (Hinckley et al., 
2005). Furthermore, a recent paper has shown that using Hb9-Cre to drive the 
expression of a fluorescent reporter labeled both ventral and dorsal neurons throughout 
the laminae of the spinal cord (Caldeira et al., 2017). Another alternative would be to 
use the VAChT promoter, but reporter expression under VAChT would be expected to 
mirror ChAT. Furthermore, Cre expression in these mice has a delayed onset (at 
postnatal day 7) and is only detected in 40-60% of motor neurons (Misawa et al., 2003).  
We could potentially bypass collection of non-somatic motor neurons by limiting 
tissue collection to the caudal lumbar spinal cord. This capitalizes on the fact that 
preganglionic visceral motor neurons are well established to only extend into the L1-L2 
regions of the lumbar cord (Stifani, 2014). Additionally, pre-motor interneurons are 
mostly cholinergic at the more rostral levels of the lumbar spinal cord, but increasingly 
become glutamatergic at more caudal positions (Zagoraiou et al., 2009). Therefore, 
limiting isolation to lower regions of the lumbar cord would not only be more 
representative of motor neurons that innervate the distal hindlimb (which corresponds to 
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muscles that are most often used for analysis), but would also limit the contribution of 
other cholinergic populations. 
In addition to the expected cholinergic populations, we were also able to detect a 
rare population cells that were RPL22HA+ChAT-. Although their origin is unclear, the 
most likely explanation for their presence is that they are an interneuron population that 
transiently expresses ChAT during development. Future studies to characterize their 
presence in regions other than the lumbar cord and determine their population sizes, 
locations, and function could be of interest. Altogether, given the current limitations, it 
will be important to supplement future analyses that identify gene expression changes in 
motor neurons with localization studies using in situ hybridization or immunostaining. 
Furthermore, our data highlights the need for new methods to improve Cre targeting 
accuracy in more defined ways (see Chapter 4). 
 We also observed gene expression patterns in different spinal cord regions that 
largely matched previously reported expression profiles used as the basis for motor 
column identity (Fig. 3.6). However, it is interesting to note that one gene (Foxp1, Fig. 
3.6I) showed no enrichment, while some others (most notably HoxC9 [Fig. 3.6J], and 
ETV1 [Fig. 3.6K]) showed significant, but relatively low levels of enrichment. This might 
reflect the fact that much of our knowledge about motor column specific gene 
expression comes from studies of development. Therefore, genes expressed during the 
early specification of motor column identity may be turned off or downregulated in the 
adult. However, another interpretation of our results involves considering the RiboTag 
methodology itself. The RPL22HA IP only enriches for genes that are actively associated 
with ribosomes. Therefore, while the total transcript abundance of a gene may be high, 
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if the rate of translation is low it might not appear to be greatly enriched. To distinguish 
between these two possibilities, future work using the RiboTag model to examine gene 
expression profiles during motor column specification could be performed. 
 After characterizing isolation of motor neuron specific transcripts from cell bodies 
in the spinal cord, we next asked if the RiboTag technology could be used to examine 
local translation in motor axons. Although our goal was to use the RiboTag mice to 
define an “axonal translatome” for motor neurons, limitations associated with leakiness 
of RPL22HA made this analysis challenging. Importantly, HA protein was not detected in 
mice that were wild-type for the RPL22HA knock-in allele (RiboWT). However, in the 
absence of Cre, low levels of HA protein could be detected in mice with either one or 
two copies of RPL22HA (Fig. 3.8). The likely explanation for these results is that 
transcriptional machinery is bypassing the stop codon intended to prevent expression of 
RPL22HA in the absence of Cre, resulting in low levels of ubiquitous RPL22HA transcript.  
In addition to HA protein expression in the muscle in the absence of Cre, two 
other lines of evidence support this idea. First, analysis of the quality of mRNAs 
associated with ribosomal IPs in the muscle (Fig. 3.7A) demonstrates that transcripts 
isolated from RiboWT mice had lower RIN values compared to the other genotypes, 
indicating that more of the associated RNA was fragmented and non-specifically 
associating with the IP. Second, we also observed the same phenomenon of a low level 
of HA protein expression in RiboHET and RiboHO after immunoprecipitation from spinal 
cord tissue (data not shown). This observation indicates that RPL22HA production in 
Cre-negative mice is not tissue specific and is likely to be inherent to all tissues of the 
RiboTag mouse. Taken together, the evidence presented here suggests that the 
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RiboTag mouse model is highly efficient at isolating tissue-specific transcripts from 
populations of cells in which the Cre-driven RPL22HA signal is expressed at high levels 
relative to background (i.e. for isolation of transcripts from motor neuron cell bodies). 
However, in situations where the expected level of transcripts is minute relative to total 
size (i.e. isolation of transcripts from motor axons in skeletal muscle), detecting the 
specific signal over noise becomes increasingly challenging. 
 Despite finding these limitations in the RiboTag methodology, we were able to 
detect significant ChAT-Cre dependent increases in RPL22HA protein (Fig 3.8) and 
mRNA (Fig 3.9) from muscle. Furthermore, bioinformatic analysis demonstrated that by 
using RiboHO mice as a control (Ctl IP), an enrichment of transcripts from the 
RiboHO;ChAT+ IP group could be detected (Fig. 3.11B). In total, we identified 114 
transcripts as enriched in motor axons, compared to 1069 enriched in motor neuron cell 
bodies. Importantly, these genes do not likely reflect the entire repertoire of axonally 
localized transcripts, but were genes significantly enriched to a level that allowed 
detection over the noise associated with the control IP. Furthermore, any gene identified 
through bioinformatic analysis (Fig. 3.14) must be validated by in situ hybridization to 
determine if transcript is actually localized within motor axons. To that end, some of the 
genes enriched in axons represent particularly interesting candidates for future 
validation. For example, Dnaic1 and Pfn4 are genes associated with axon transport and 
the cytoskeleton, which are both processes crucial to motor neuron health and survival 
(Williamson and Cleveland, 1999; Willis and Twiss, 2006; Maximino et al., 2014). 
Furthermore, another member of the Profilin family (Pfn1) has recently been linked to 
ALS (Wu et al., 2012; Figley et al., 2014). 
78 
 
 Although RT-qPCR was used to demonstrate the specificity of select genes, 
bioinformatic analysis showed more globally that many transcripts were significantly 
enriched in motor neuron cell bodies after RPL22HA IP (Fig. 3.10 - 3.11). Both GO (Fig. 
3.12) and KEGG (Fig. 3.13) analyses pointed to metabolic processes and oxidative 
phosphorylation as the most highly represented pathways in motor neurons. These 
findings are not all that surprising given that motor neurons are metabolically 
demanding cells and mutations that disrupt metabolism have been linked to motor 
neuron disease (Sas et al., 2007; Johri and Beal, 2012; Ngo and Steyn, 2015). 
Furthermore, among the most highly enriched transcripts were genes that have been 
well-associated with motor neuron identity, including: Hb9, Isl1, Isl2, Lhx3, Lhx4, ChAT, 
VAChT, and Acetylcholine esterase (AChE). Additionally, many other genes including 
those important for regulation of the cytoskeleton and neurotransmission were also 
significantly enriched. 
 After characterizing the RiboTag;ChAT-Cre mouse model, we demonstrated that 
it can be applied for the sensitive detection of gene expression changes after nerve 
crush injury (Fig. 3.15). Interestingly, apart from p75 (Fig. 3.15G), changes in response 
to nerve crush could not be detected in the whole cell lysates. However, enrichment of 
motor neuron specific transcripts demonstrated that genes were both up- and down-
regulated 7 days after injury. In accordance with previous studies, GAP43, p75, and 
BDNF (Fig. 3.15F, H, J) were all observed to increase after injury (Chong et al., 1992; 
Hayes et al., 1992; Ikeda et al., 2001; De Winter et al., 2006; Meeker and Williams, 
2014). Furthermore, the extent of BDNF upregulation was comparatively small, which 
potentially matches previous studies that found the highest levels of BDNF expression 
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occur within one day of the initial injury during the acute phase of the response. On the 
other hand, ChAT expression levels were found to significantly decrease after injury 
(Fig. 3.15D). This finding is consistent with previous studies that have found a reduction 
in ChAT expression following nerve crush (Armstrong et al., 1991) and in ALS patients 
(Nagata et al., 1982). Finally, given that our gene expression analysis at the D7 time 
point suggests this model works effectively, future analyses including more time points 
will likely reveal mechanisms that govern how motor neurons respond to a peripheral 
injury. Another particularly interesting comparison would be between the nerve crush 
and nerve cut injuries. By understanding the molecular mechanisms that underlie 
successful and unsuccessful nerve regeneration, such a comparison might reveal novel 
ways to combat peripheral nerve injury to improve regenerative outcomes. 
 Lastly, we applied the RiboTag;ChAT-Cre model to neurodegeneration by 
crossing the RiboTagHO;ChAT-Cre+ line with the SOD1G93A mouse model. Although we 
have not yet examined specific gene expression alterations, early evidence suggests 
that we can detect more global changes in translational activity during the early 
symptomatic phase (P90). Specifically, there is an increase in both the amount of RNA 
isolated after RPL22HA IP (Fig. 3.17A) and in the association of p-S6 with 
immunoprecipitated ribosomes (Fig. 3.18G). While it might not be surprising that there is 
an increase in translational activity during disease onset when motor neurons are 
actively trying to compensate for loss of innervation at the NMJ, our data does not 
match a recent study using the ChAT-BAC-TRAP model with SOD1G37R mice (Sun et 
al., 2015). Interestingly, the authors found that there was a significant reduction in 
overall gene expression of both ribosomal components and translational machinery in 
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SOD1G37R mice. Furthermore, in spinal cord sections, they observed an increase in 
phosphorylated eIF2α (p-eIF2α), which is associated with inhibition of translational 
activity (Raven and Koromilas, 2008).  
Although we did not see signs of reduced translation at the early P90 time point, 
translational defects were more apparent at the terminal time point (P150). While there 
were no differences in the amount of isolated RNA (Fig. 3.17B) or RPL22HA protein (Fig. 
3.18D) detected in ALS and WT mice, we did observe a specific decrease in co-
immunoprecipitated p-S6 (Fig. 3.18H). Though it might be expected that motor neuron 
cell death at the terminal time point would lead to a general decrease the amount of 
isolated RNA and RPL22HA protein in motor neurons, our results might be interpreted in 
a few ways. One intriguing idea is that RPL22HA protein is caught within toxic 
aggregates common to many models of ALS. In support of this idea, such aggregates 
are known to sequester protein factors that are needed for normal cell function and 
have been characterized to be translationally active themselves (Yasuda et al., 2013). 
On the other hand, our results might reflect that there are increasingly more stalled 
transcripts on RPL22HA-tagged ribosomes. Future studies to investigate changes in 
motor neuron gene expression at the P90 and P150 time points, in addition to 
histological studies looking at the level of RPL22HA, p-S6, and eIF2α will aid in 
deciphering how translational activity is altered in the face of neurodegeneration. 
Taken together, the work presented in this chapter represents a detailed 
characterization and demonstration of how the RiboTag model can be applied to the in 
vivo study of motor neuron gene expression. Furthermore, by pushing the detection 
limits of this model, we have found that low levels of nonspecific RPL22HA are produced 
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in a Cre-independent fashion. Despite this limitation, by using appropriate controls we 
identified putative motor axon transcripts that can be characterized in future 
experiments. Finally, by applying the RiboTag;ChAT system to models of nerve crush 
injury and neurodegeneration we highlight the value that this model can serve in 
increasing our understanding of how motor neurons respond to changes in their 
environment. Furthermore, through this process, we hope to uncover novel mechanisms 
that can be exploited to provide new therapeutic strategies for the treatment of 
peripheral nerve injuries and MND. 
 
Experimental Procedures 
Animals. All housing and procedures performed on mice were approved by the 
Institutional Animal Care and Use Committee (IACUC) of the University of Michigan. 
Wild-type C57BL/6J (000664), RiboTag (B6N.129-Rpl22tm1.1Psam/J, 011029), ChAT-
IRES-Cre (B6;129S6-Chattm(cre)Lowl/J, 006410), R26/CAGmTmG (B6;129S6-
Gt(ROSA)26Sortm1(CAG-tdTomato*,-EGFP*)/Ees/J, 023035) and B6.SOD1-G93A (B6.Cg-
Tg(SOD1*G93A)1Gur/J, 004435) mice were obtained from Jackson Laboratories (Bar 
Harbor, ME). RiboTag conditional mice were crossed with ChAT-Cre mice to generate 
RiboHet;ChAT+ and RiboHO;ChAT+ experimental mice. Additionally, C57BL/6J mice and 
RiboWT;ChAT+ mice were used as RiboWT controls, while RiboHet;ChATWT and 
RiboHO;ChATWT littermates were used as Ribo+ controls. Finally, for some experiments, 
B6.SOD1-G93A mice were crossed into the RiboTag;ChAT-Cre line to create a triple-
transgenic line. All mice were genotyped according to publicly available protocols and 




Nerve Crush. Mice were deeply anesthetized with 2-3% isoflurane mixed with oxygen 
and the surgical site was shaved and disinfected. Two sciatic nerve crush sites were 
used for different experiments. In some instances, the common peroneal branch of the 
sciatic nerve was crushed (as described and characterized in Chapter 2), while for other 
experiments the sciatic nerve was injured at the mid-thigh level to denervate a larger 
region of the hindlimb. For both crush sites, a small incision was made through the skin 
and overlying musculature to expose the sciatic nerve. The exposed nerve was then 
crushed by applying pressure with a pair of forceps for 40 sec. Following the crush 
procedure, the muscle was closed with a suture and the skin was sutured at the incision 
site. In a small number of experiments, a nerve cut was performed instead of a nerve 
crush. In these instances, the same procedure was performed except that a 3-5mm 
piece of nerve was excised as opposed to being crushed with forceps.  
 
HA Immunoprecipitation and RNA Isolation. Tissues were harvested and snap 
frozen in liquid nitrogen. Homogenization and HA immunoprecipitation (IP) were largely 
performed as previously described by Sanz et al., 2009. Briefly, tissues were placed into 
IP buffer (50 mM Tris, pH 7.4, 100 mM KCl, 12 mM MgCl2, 1% Nonidet P-40 [NP-40] 
supplemented with 200 U/mL Promega RNasin, 1 mg/mL heparin, 100 µg/mL 
cycloheximide, and protease inhibitor mixture [Sigma-Aldrich]) and subjected to Dounce 
homogenization. Samples were then rotated at 4°C for 15-20 minutes followed by 
centrifugation at 10,000 x g for 10 min at 4°C to generate a postmitochondrial 
supernatant. A 50 µl aliquot of the whole cell lysis (WCL) was saved and processed 
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separately for protein and/or RNA analysis. The remainder of the sample was 
precleared with Protein G magnetic beads (25 µl of beads per 200 µl of supernatant, 
New England Biolabs) for 1 hour under constant rotation at 4°C. After preclearing, 
samples were separated from magnetic beads and incubated with HA antibody (1:150 
dilution, MMS-101P, BioLegend) and toppled for 4 hours 4°C. Finally, Protein G 
magnetic beads were added and allowed to incubate under rotation overnight. The 
following day, samples were placed on a magnetic rack and supernatants were 
collected. The IP product associated with the magnetic beads was then washed three 
times in a high salt buffer (50 mM Tris, pH 7.4, 300 mM KCl, 12 mM MgCl2, 1% NP-40 
supplemented with 100 µg/mL cycloheximide). RNA associated with the HA IP was then 
isolated using the RNeasy Plus Micro Kit (Qiagen) per manufacturer instructions. 
 
Bioanalyzer Analysis, cDNA Preparation, and qRT-PCR. The concentration of 
isolated RNA was determined by running samples on a 2100 Bioanalyzer Instrument 
(Agilent Genomics). cDNA was then synthesized with the remainder of the RNA sample 
(~12 µl) using the Superscript III First-Strand Synthesis SuperMix kit (Invitrogen) and 
subsequent RT-qPCR was performed using a 7900HT Fast Real-Time PCR System 
(Applied Biosystems) with the appropriate primer set (Table 3-1) and FastStart 
Universal SYBR Green Master Mix (Roche). 
 
HA Immunoprecipitation for Western Blotting. Muscle or spinal cord samples were 
dissected and placed into immunoprecipitation buffer (10% glycerol, C0mplete protease 
inhibitors (Roche), and sodium vanadate in Tris buffered saline (TBS), pH 6.8). Tissues 
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were homogenized with the Tissue Lyser II (Qiagen) set at 30 Hz for 5min. Samples 
were then detergent extracted by the addition of nonidet p-40 (1% final concentration) 
followed by constant rotation for 30 min at 4°C and insoluble material was removed by 
centrifugation for 5 min at maximum speed in a microfuge. Before HA 
immunoprecipitation (IP), samples were first precleared with Protein G agarose beads 
(Roche) for 1 hr before the HA IP was performed overnight with HA antibody (1:150 
dilution, MMS-101P, BioLegend) and Protein G beads. For all incubations, samples 
were left under constant rotation at 4°C. The next day samples were lightly centrifuged 
(5000 rpm, 5 min) and the supernatant was collected and denatured in 2x sodium 
dodecyl sulfate (SDS) sample buffer (20% glycerol, 4% SDS, 1% β-mercaptoethanol, 
and bromophenol blue in TBS, pH 6.8) by heating for 10 min at 100°C. Meanwhile, the 
immunoprecipitated product was washed three times with immunoprecipitation buffer 
followed by denaturation in the same manner as described for the supernatants. 
 
Protein Isolation after RNA Lysis and Processing. In some instances, protein was 
co-purified with RNA isolated using the RNeasy Plus Micro Kit (Qiagen). Once RNA 
binds to the RNA-binding cup, protein in the flow-through was precipitated with ice-cold 
acetone for 30 min on ice. Samples were then centrifuged for 10 min at max speed to 
pellet the protein precipitate. The protein was then washed with 100% ice-cold ethanol, 
centrifuged again, and resuspended in water. Finally, the protein was denatured by 




Immunoblotting. All samples were resolved on a 12 or 14% (SDS)-polyacrylamide gel 
electrophoresis (SDS-PAGE) gel and transferred to polyvinylidene fluoride (PVDF) 
membranes. Membranes were blocked in 4% Milk in TBS-T (Tris buffered saline, pH 7.4 
and 0.1% Tween-20) for 1hr at room temperature. Primary antibodies [α-Tubulin 
(1:30,000, T9026, Sigma-Aldrich), Actin (1:1,000, SC-1616-G, Santa Cruz), HA 
(1:1,000, #3724, Cell Signaling), Synapsin-1 (1:1,000, #5297, Cell Signaling), ChAT 
(1:1,000, AB144P, Millipore), and Phospho-S6 Ribosomal Protein (p-S6, 1:1,000, 
#4858, Cell Signaling)] were diluted in 3% bovine serum albumin (BSA) and incubated 
overnight at 4°C. The following day, membranes were washed and incubated with 
appropriate horseradish peroxidase (HRP)-linked secondary antibodies (1:10,000) in 
3% BSA (Jackson ImmunoResearch) followed by visualization with a chemiluminescent 
substrate (Thermo Scientific). Western blot quantification was performed by 
densitometric analysis in ImageJ (NIH). The signal intensity in arbitrary units was 
determined for the amount of HA protein in the IP and the amount of loading control in 
the supernatant. After normalization to the loading control, data was also normalized to 
the average value calculated for the wild-type controls. 
 
Tissue Preparation. Mice were transcardially perfused with phosphate-buffered saline 
(PBS) followed by 4% paraformaldehyde (PFA, Electron Microscopy Sciences). The 
lumbar spinal cord was then carefully dissected and post-fixed in 4% PFA at 4°C 
overnight. The next day tissues were washed 3x20min in PBS and soaked for at least 
one day in 30% sucrose at 4°C. Spinal cords were then embedded in O.C.T compound 
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(Tissue-Tek) and frozen at -80°C. 30µm transverse cryosections were cut using a 
CM1950 cryostat (Leica Biosystems). 
 
Immunostaining. Sections were rehydrated in PBS and then antigen retrieval was 
performed by incubating slides in boiling 10 mM sodium citrate buffer, pH 6.0 for 3 min. 
After cooling slides briefly in PBS, sections were permeabilized/blocked in 0.3% 
TritonX-100, 1% BSA, 10% donkey serum (Jackson ImmunoResearch), and MOM 
blocking reagent (Vector Laboratories) for 1hr at room temperature. Slides were then 
incubated with primary antibodies [HA (1:100, #3724, Cell Signaling), ChAT (1:100, 
AB144P, Millipore), NeuN (1:100, MAB377, Millipore), Glial fibrillary acidic protein 
(GFAP, 1:200, ab4674, Abcam), and Microtubule-associated protein 2 (MAP2, 1:100, 
ab3096, Abcam)] in 0.3% Triton, 1% BSA overnight at room temperature. The following 
day sections were washed in PBS and stained with the appropriate secondary 
antibodies (Biotium) in 0.3% Triton for one hour at room temperature. After final PBS 
washes, slides were coverslipped with DAPI mounting medium (Southern Biotech) and 
imaged on a confocal microscope (Leica SP5). 
 
cDNA Library Construction and RNA-Seq.  
The purity and quality of isolated RNA was checked by Bioanalyzer. Samples were then 
submitted to the University of Michigan Sequencing Core for cDNA Library construction 
and Sequencing. Briefly, ribosomal depletion was performed with the RiboGone 
Mammalian Kit (#634847, Clontech). Due to differences in the quantity of isolated RNA, 
60 ng of total RNA from RiboHO;ChAT+ mice and 15 ng of total RNA from RiboHO mice 
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were input into the RiboGone Kit. After ribosomal depletion, cDNA synthesis was 
performed with 13 rounds of amplification using the SMARTer® Universal Low Input 
RNA Kit for Sequencing (#634940, Clontech). Samples were then sequenced using 
single-end, 50 bp reads on the HiSeq 2500 System to obtain 50 to 100 reads. 
 
Bioinformatic Analysis. 
Quality was assessed with FastQC and Cutadapt was used to remove barcodes. 
Sequence reads were aligned to the mouse genome (mm10) using Star Aligner (version 
2.5). Align statistics were then assessed with RSeQ. Reads falling inside genes were 
quantified with htseq-count, while reads at splice junctions were quantified by DEXseq. 
Differential gene expression analysis was then performed with DESeq2 and plotted with 
ggplot2. Heatmaps and Venn diagrams were generated using heatpmap3 and 
Venerable packages, respectively. Finally, GO and KEGG enrichments were performed 
with GO.db and ClusterProfiler. 
 
Statistical Analysis. 
All statistical analyses were performed using Prism 7 software (GraphPad). One- or 
two-way ANOVA was used for all analyses. Significant differences among pairwise 
comparisons were identified by Tukey’s post hoc tests. 
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Gene Forward Primer (5’ – 3’) Reverse Primer (5’ – 3’) BP Source 
Actin GGCTGTATTCCCCTCCATCG CCAGTTGGTAACAATGCCATGT 154 Harvard PrimerBank 
ChAT CCATTGTGAAGCGGTTTGGG GCCAGGCGGTTGTTTAGATACA 136 Harvard PrimerBank 
Calbindin GGCTTCATTTCGACGCTGAC ACGTGAGCCAACTCTACAATTC 184 Harvard PrimerBank 
CNPase ACGAGTGCAAGACGCTATTC CCGCTCGTGGTTGGTATC 242 (Sanz et al., 2009) 
Isl1 TACGTGCTTTGTTAGGGATGGG CTGCACTTGGCGCATTTGAT 81 Harvard PrimerBank 
Alcam ATGGCATCTAAGGTGTCCCCT CTGAGTTGACAGTGTACCATCC 100 Harvard PrimerBank 
Foxp1 CACCTCAGGTTATCACTCCTCA AGCTGCAACTGTTCCTGTTGT 157 Harvard PrimerBank 
HoxC9 GCAGCAAGCACAAAGAGGA CGTCTGGTACTTGGTGTAGGG 113 (Jespersen et al., 2013) 
Etv1 GGTCTGCTTGCAGTCAAGAG GGTTTCGGAGTATGAGCTGTGT 184 Harvard PrimerBank 
nNOS AGCACCTACCAGCTCAAGGA ATAGTGATGGCCGACCTGAG 209 Primer3 
Pitx2 GAGGTGCATACAATCTCCGATA TGCCGCTTCTTCTTGGAC 113 (Kahr et al., 2011) 
GAP43 ATAACTCCCCGTCCTCCAAGG GTTTGGCTTCGTCTACAGCGT 201 Harvard Primer Bank 
P75 CAACCAGACCGTGTGTGAAC GGAGAACACGAGTCCTGAGC 235 Primer3 
BDNF TCATACTTCGGTTGCATGAAGG AGACCTCTCGAACCTGCCC 137 
(Arthur-


















































































Figure 3.1. RPL22HA+ Cell Populations in the Lumbar Spinal Cord. 
RPL22HA is expressed in four major populations of cells in the spinal cord under the ChAT-Cre promoter. A, A 
representative image of a transverse section of a spinal cord is stained with ChAT (blue), NeuN (green), and 
RPL22HA (red). The insets (B-E) illustrate regions where the different cell populations are found. B, RPL22HA+ 
cholinergic interneurons are observed around the central canal. C, Preganglionic visceral motor neurons that extend 
axons to the autonomic ganglia are observed in the lateral horn. D, A rare population of HA+ChATneg cells are 
routinely observed in the upper aspect of the ventral horn. E, Somatic motor neurons are clearly observed in the 


















































Figure 3.2. Quantification of RPL22HA Expression in Somatic Motor Neurons. 
Lumbar spinal cords were stained for ChAT (blue), NeuN (green), and RPL22HA (red). A-H, Representative spinal 
cord hemisections from RiboHet;ChATWT (A-D) and RiboWT;ChAT+ (E-H) mice are shown. ChAT+ motor neurons in the 
ventral horn of the spinal cord show strong HA immunoreactivity in RiboHet;ChAT+ (G), but not RiboHet;ChATWT (C) 
mice. I-L, A magnified image of the cells highlighted in H illustrates the two populations of somatic motor neurons. 
ChAT+NeuN+HA+ alpha motor neurons (αMNs, open arrowhead) and ChAT+NeuN-HA+ gamma motor neurons (γMNs, 
asterisks). M, Somatic motor neurons in serial lumbar spinal cord sections were analyzed for HA expression. 
RPL22HA was observed in nearly all αMNs and γMNs in RiboHet;ChAT+ mice (n = 3) and no inappropriate HA staining 






Figure 3.3. RPL22HA is Observed in Motor Neuron Dendrites but not Glial Cells.  
Immunostaining of lumbar spinal cord sections was performed to examine the extent of GFAP and MAP2 
colocalization with RPL22HA in glial cells and in motor neuron dendrites, respectively. A-C, GFAP+ (blue) astrocyte 
processes were observed in the vicinity of HA+ motor neurons (red), but do not express detectable levels of RPL22HA. 
D-E, RPL22HA immunostaining was observed extending outside the motor neuron cell body and colocalizing with 






Figure 3.4. RPL22HA can be Immunoprecipitated from Spinal Tissue in a Gene Dosage-Dependent Manner. 
Spinal cords were isolated from RiboHet;ChAT+ (n = 9, HET), RiboHO;ChAT+ (n =10, HO), and wild-type (n = 17, WT) 
littermates representing RiboWT;ChAT+, RiboHet;ChATWT, and RiboHO;ChATWT genotypes. A, Representative 
immunoblots demonstrate that RPL22HA is readily detected in spinal cord whole cell lysates (WCLs). Additionally, 
after immunoprecipitation RPL22HA becomes highly enriched in the immunoprecipitated product (IP) and depleted in 
the supernatant (SUP). B, SUPs were immunoblotted for actin as a loading control. C, The amount of 
immunoprecipitated RPL22HA in WT, HET, and HO samples was quantified across all experiments and normalized to 
the amount of actin in corresponding SUP samples. Means are relative to SUP actin across experiments 
demonstrates there is a gene dose-dependent amount of HA protein in spinal cord lysates. Error bars represent the 







Figure 3.5. Isolation of RNA following RPL22HA Immunoprecipitation from Spinal Tissue. 
A-B, RNA was isolated after HA immunoprecipitation and subjected to Bioanalyzer analysis (WT, n = 14; 
RiboHET;ChAT+, n = 4; RiboHO;ChAT+, n = 16). RIN values demonstrate that high-quality RNA can be routinely 
isolated from all sample types (A). Similar to HA protein, the amount of isolated RNA obtained after IP occurs in a 
gene-dosage dependent manner (B). C-D, Isolated RNA from WT (n = 9), RiboHET;ChAT+ (n = 6), and RiboHO;ChAT+ 
(n = 9) mice were analyzed by RT-qPCR for positive- (choline acetyltransferase [ChAT]) and negative-control genes 
(calbindin and 2’,3’-Cyclic-nucleotide 3’-phosphodiesterase [CNPase] known to be expressed in interneurons and 
oligodendrocytes, respectively). Results are represented by both percent input (C) and fold enrichment of 
RiboHET;ChAT+ and RiboHO;ChAT+ mice over WT littermates (D). In all cases a dramatic enrichment of ChAT and 
absence of the negative-control genes demonstrate the specificity of RNA isolated after IP. For A-B, error bars 





Figure 3.6. Region Specific Isolation of RNA and Transcript Analysis. 
A, The schematic illustrates the four major divisions of the spinal cord (C1-C5: cervical; T1-T12: thoracic; L1-L5: 
lumbar; S1-S5: sacral). Additionally, the relative location of the different motor columns is depicted by the boxes to 
the right of the spinal cord. Some genes are known to be expressed more globally in motor neurons of many motor 
columns (Global, gray box). The spinal accessory column (SAC, yellow box) contains motors neurons found in the 
cervical spinal cord that innervate head and neck muscles, while the lateral motor column (LMC, orange boxes) 
contain motor neurons in the cervical and lumbar spinal cord that project to the forelimbs and hindlimbs, respectively. 
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Finally, the hypaxial motor column (HMC, cyan box) and preganglionic motor column (PMC, blue box) expand 
throughout the thoracic spinal cord and are responsible for innervating the axial muscles of the trunk (HMC) and 
autonomic ganglia of the sympathetic nervous system. B-C, Spinal cords were isolated from RiboHO;ChATWT (RiboHO, 
n = 3) and RiboHO;ChAT+ (n = 4) mice and separated into three regions: cervical (SC-C), thoracic (SC-T), and lumbar 
(SC-L). An HA IP was then performed on each region separately and RNA was isolated from a fraction of the whole 
cell lysis (WCL) before the IP and after the HA IP. Bioanalyzer analysis was then used to determine the amount of 
RNA in all samples. A similar amount of RNA was isolated in all WCL samples from RiboHO littermate mice and 
RiboHO;ChAT+ mice from the various spinal cord regions (B). After HA IP, the specificity of the IP is demonstrated in 
the enrichment of RNA in RiboHO;ChAT+ mice. D-M, RiboHO;ChAT+ IP and WCL RNA was examined for region-
specific gene expression patterns. For all genes examined, samples were first normalized to actin and then gene 
expression of the IP is displayed relative to its expression in the corresponding WCL sample. The negative control 
genes Calbindin and CNPase illustrate that genes not expressed by motor neurons are de-enriched after HA IP 
(D,E). Islet1 (Isl1) and Choline acetyltransferase (ChAT) are broadly expressed by motor neurons in motor columns 
that span the entirety of the spinal column (F-G). Activated leukocyte adhesion molecule (ALCAM), known to be 
expressed by motor neurons of the SAC, was found to be highly enriched in the SC-C (H). Forkhead Box P1 (Foxp1) 
was expected to be found in LMC motor neurons; however, we did not find enrichment in any of the spinal cord 
regions (I). Homeobox C9 (HoxC9), ETS variant 1 (ETV1), and Neuronal nitric oxide synthase (nNOS) all showed 
varying degrees of upregulation in the SC-T (J-L). Paired-like homeodomain transcription factor 2 (Pitx2) is known to 
be expressed by cholinergic pre-motor interneurons that reside near the central canal. In all three regions, an 
enrichment of Pitx2 expression was observed, with the highest levels in the SC-T (M). Error bars represent the mean 

































Figure 3.7. The ChAT promoter drives Cre expression specifically in cholinergic motor axons in the skeletal 
muscle. 
ChAT-Cre mice were crossed to R26/CAGmTmG reporter mice that ubiquitously express tdTomato in all cells in the 
absence of Cre. However, when Cre is expressed, the tdTomato construct is removed and an enhanced green 
fluorescent protein (eGFP) construct is produced (A). Strong eGFP expression (blue) was observed in the skeletal 
muscle colocalizing with ßIII-tubulin+ nerve fibers that innervate endplates labeled with bungarotoxin (BTX, green) (B) 
No eGFP expression is observed in ßIII-tubulin+ nerve fibers that travel along blood vessels (C, arrowheads). The 






Figure 3.8. RPL22HA Protein can be Immunoprecipitated from Motor Axon Terminals Innervating Skeletal 
Muscle.  
Quadriceps (Quad) or gastrocnemius (GP) muscles were isolated from C57BL/6 or RiboWTChAT+ mice (RiboWT, n = 8 
[Quad], n = 9 [GP]), RiboHetChATWT or RiboHOChATWT mice (Ribo+, n = 7 [Quad], n = 9 [GP]), RiboHetChAT+ mice (n = 
5 [Quad], n = 7 [GP]), and RiboHOChAT+ mice (n = 10 [Quad], n = 18 [GP]). HA immunoprecipitation was then 
performed and the immunoprecipitated product was examined by western blot. A, The representative western 
demonstrates HA protein observed after IP from quadriceps muscle. A strong RPL22HA signal is observed at the 
predicted weight (~23 kDA) in RiboHOChAT+ mice. Additionally, all mice carrying 1- to 2- copies of RPL22HA (Ribo+ 
and RiboHET;ChAT+) exhibit a low-level HA protein band, while mice that are RiboWT (C57BL/6 and RiboWT;ChAT+) 
show no detectable levels of HA protein, even under the longest exposure times. For all samples, supernatants were 
immunoblotted for αTubulin (αTub) as a loading control. B-C, Quantification of all experiments performed in 
quadriceps (B) and gastrocnemius (C) muscles is graphed. The amount of HA protein detected in the IP is 
normalized to αTub in the corresponding supernatant sample. A clear increase of RPL22HA protein is detected in 
skeletal muscle of RiboHO mice in a ChAT-Cre dependent manner. Error bars represent the mean ± s.e, ** p ≤ 0.01, 






























Figure 3.9. Isolation of RNA following RPL22HA Immunoprecipitation from Skeletal Muscle. 
RNA was isolated after HA immunoprecipitation and subjected to Bioanalyzer analysis (RiboWT, n = 16; Ribo+, n = 19, 
RiboHet;ChAT+, n = 7, RiboHO;ChAT+, n = 33). A, RIN values demonstrate that high-quality RNA can routinely be 
isolated from all sample types, with slightly more degraded RNA found after HA IP from RiboWT mice. B-C, The 
enrichment of RNA in RiboHO;ChAT+ mice is depicted in two ways: the raw concentration (ng/µl, B) and normalized to 
the WT samples run in each independent experiment (C) followed by log transformation. For all graphs, error bars 






Figure 3.10. Novel Gene Discovery from Motor Cell Bodies and Distal Axon Terminals.  
A, Spinal cord tissue (SC) and the gastrocnemius muscle (GP) were isolated from RiboHO (n = 3) and RiboHO;ChAT+ 
(n = 3). HA IPs were performed on the different tissues independently, followed by RNA isolation and RNA-Seq 
analysis. B-C, Differential gene expression was performed to compare transcripts isolated after HA IP from 
RiboHO;ChAT+ mice (IP) to that from RiboHO mice (Ctl IP). RNA from WCLs before HA IP was also sequenced and 
compared as an additional control. Heat maps from SC (B) and GP (C) tissues display the relative gene expression 
for the 100 most statistically significant genes, where dark blue represents highly expressed genes and light green 






Figure 3.11. Enrichment after RPL22HA Immunoprecipitation.  
A-B, Volcano plots showing individual genes enriched in the IP (red dots with a positive log2Fold Change) vs. the Ctl 
IP (red dots with a negative log2Fold Change) are graphed. For both SC (A) and GP (B) tissues, transcripts are 
skewed to the top-right, indicating there is an enrichment after HA IP from RiboHO;ChAT+ mice. C, The venn diagram 
illustrates the number of transcripts identified as enriched over the Ctl IP in the spinal cord (1066 transcripts) 




























































Figure 3.12. GO-Analysis of Transcripts Enriched in Motor Neuron Cell Bodies.  
Gene ontology (GO) enrichment analysis was performed on the 1066 transcripts identified as enriched in RPL22HA IP 
from RiboHO;ChAT+ mice over the Ctl IP performed using RiboHO tissue. Categories with more representation have 
higher gene ratios (x-axis). The count reflects the number of genes within the GO term that are represented, while 






Figure 3.13. KEGG Analysis of Transcripts Enriched in Motor Neuron Cell Bodies.  
A-B, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways analysis was performed on transcripts identified 






Figure 3.14. KEGG Analysis of Transcripts Identified in Motor Neuron Cell Bodies and Axons.  
A-B, KEGG analysis of transcripts identified in motor neuron cell bodies and axons was performed. The relationship 
between overrepresented categories is illustrated in the diagram with genes enriched in cell bodies displayed in 





















































Figure 3.15. Changes in Motor Neuron Gene Expression Following Sciatic Nerve Crush.  
The right sciatic nerve of RiboHO (n = 5) and RiboHO;ChAT+ (n = 5) mice were crushed at the level of the mid-thigh. 
After 7 days, the lower 2/3 of the lumbar spinal cord was isolated. The left uninjured (UNI) and right D7 injured (D7) 
hemispheres of the spinal cord were separated and processed independently for HA IP. A-B, Bioanalyzer analysis 
was performed on all samples and RNA concentrations in WCL (A) and IP (B) samples is graphed. Similar levels of 
RNA were observed in all WCL samples, while significantly more RNA was detected in IPs from RiboHO;ChAT+ mice 
compared to RiboHO controls. C-J, RT-qPCR was used to examine various genes in WCL (C, E, G, I) and IP (D, F, H, 
J) samples. In most cases (except P75, G) similar levels of gene expression were observed in the WCLs and a highly 
significant enrichment of transcript was observed in RiboHO;ChAT+ mice compared to RiboHO controls. Additionally, 
there was an injury-dependent decrease of ChAT expression (D), while GAP43 (F), p75 neurotrophin receptor (P75, 
H), and brain derived neurotrophic factor (BDNF, J) expression significantly increased in response to sciatic nerve 

















































Figure 3.16. RPL22HA is Significantly Enriched in Motor Axons in Response to Nerve Crush.  
RiboHO control littermates (n = 9) and RiboHO;ChAT+ (n = 5) mice underwent a common peroneal nerve crush. Injured 
and uninjured tibialis anterior muscles (TAs) were collected 7 days after injury. A, Representative western blots from 
SUP samples demonstrate that nerve crush results in an upregulation of αTub protein, while the presynaptic protein 
synapsin is downregulated. B, RPL22HA and phoshpo-S6 Ribosomal protein (p-S6, a marker for increased 
translational activity) were detected in the IP after injury, while much lower levels were observed in the contralateral 













































Figure 3.17. Isolation of Motor Neuron Specific Transcripts from ALS Mice.  
The RiboTag;ChAT mouse line was crossed into the SOD1G93A amyotrophic lateral sclerosis (ALS) mouse model. 
ALS RiboHO;ChAT-Cre+, WT RiboHO;ChAT-Cre+, ALS RiboHO, and WT RiboHO mice were aged to early symptomatic 
time point at 3 months (P90) or a terminal time point at 5 months (P150). RPL22HA IPs were performed from isolated 
lumbar spinal cords and isolated RNA concentrations were determined by Bioanalyzer analysis. A-B, At the P90 time 
point there is a significant increase in the amount of isolated RNA obtained from ALS RiboHO;ChAT+ mice as opposed 
to WT RiboHO;ChAT+ littermates (A). ALS RiboHO;ChAT+ and WT RiboHO;ChAT+ mice had similar amounts of RNA 


































Figure 3.18. p-S6 Co-Immunoprecipitation May Indicate the Translational State of Ribosomal Complexes.  
A-H, Representative western blots of WCL and HA IP samples isolated from ALS and WT RiboHO;ChAT+ mice and 
littermate controls at the P90 (A,C,E,G) and P150 (B,D,F,H) time points. Both αTub and ChAT protein expression in 
the WCLs are shown as loading controls (A,B). RPL22HA protein in WCLs was not detected in RiboHO controls, but 
was readily detectable at both time points examined in ALS and WT RiboHO;ChAT+ mice (C,D). p-S6 in WCLs and co-
IPs was then examined as a marker of translational activity. At both time points, p-S6 is observed in WCLs of all mice 
examined (E,F), while in the IP it was only detectable in RiboHO;ChAT+ mice (G,H). Furthermore, the level of p-S6 in 
the IP was greatly increased in ALS RiboHO;ChAT+ mice compared to WT RiboHO;ChAT+ controls at the P90 time 
point (G), while it was barely detectable in ALS RiboHO;ChAT+ mice by the terminal P150 time point (H).
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CHAPTER 4: CONCLUSION 
 
Regulation of Motor Innervation at the Neuromuscular Junction 
 The mechanisms that govern reinnervation of the neuromuscular junction (NMJ) 
are complex, but many studies have begun to tease apart the various signaling 
molecules involved (Schmidt et al., 2009). In the work presented here, we have sought 
to contribute to that understanding. Specifically, we have established a sciatic nerve 
crush injury model that allows for the quantitative assessment of NMJ reinnervation, 
examined the functional significance of Semaphorin3A (Sema3A) signaling at the adult 
NMJ, and developed an unbiased means for identifying novel pathways that regulate 
NMJ reinnervation. 
 Previous work had suggested that Sema3A might establish an inhibitory 
environment that negatively impacts motor axon regeneration and NMJ reinnervation. 
Therefore, it was proposed that specifically reducing Sema3A at the NMJ might have a 
therapeutic potential for treating sciatic nerve crush injury and neurodegenerative 
disease. To directly test this hypothesis, we developed a common peroneal sciatic 
nerve crush model and used histological methods to carefully interrogate different 
phases of NMJ reinnervation. We then used that model in conjunction with conditional 
knockout mice to examine how NMJ reinnervation is impacted in the absence Sema3A 
signaling. However, loss of Sema3a or of its high-affinity receptor Neuropilin1 (Npn1) 
did not disrupt the normal maintenance or improve regeneration of the NMJ.  
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 Next, to identify novel mediators of NMJ innervation, we developed a rapid and 
unbiased method to isolate motor neuron specific transcripts from complex tissues in 
vivo. This was achieved by using RiboTag technology to incorporate an HA tag on 
Ribosomal Protein RPL22 (RPL22HA) in cholinergic neurons. We then demonstrate that 
this model can be used to study motor neuron specific gene expression and local 
translation in motor axons. 
 Taken together, we believe the work presented here will lead to future studies 
that will continue to uncover the molecular mechanisms employed by motor neurons 
during times of health, injury, and disease. In the following sections, we consider 
outstanding questions and important future directions for the field. 
 
Outstanding Questions and Future Directions 
Semaphorin 3A Signaling at the Neuromuscular Junction 
Although our study found that Sema3A signaling was not required for adult NMJ 
maintenance or regeneration after injury, there are still outstanding questions that need 
to be addressed. First, we still have a poor understanding of the different cell type(s) 
that express the various components necessary for Sema3A signaling in adult muscle. 
Motor neurons have been described to express Npn1 mRNA (De Winter et al., 2006; 
Molofsky et al., 2014; Venkova et al., 2014) and using the RiboTag;ChAT-Cre model we 
were able to demonstrate that as well [data not shown]. Additionally, mRNA for 
PlexinA1-A4 (PlexA1-A4) has been demonstrated in motor neurons by in situ 
hybridization (De Winter et al., 2006). Therefore, although the components for Sema3A 
signaling are present, where those receptors localize to and how they are regulated in 
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response to different stimuli is unclear. There is some evidence that Npn1 protein is 
expressed at motor axon terminals at the NMJ (Venkova et al., 2014). We have also 
attempted to characterize Npn1 protein expression at the NMJ, but non-specificity of the 
antibody made that analysis difficult to interpret. Despite this limitation, by using 
synaptic and extra-synaptic preparations from skeletal muscle, we have been able to 
show Npn1 protein is more concentrated synaptically than extrasynaptically [data not 
shown]. Furthermore, while some studies have tried to address Npn1 localization, the 
PlexA family member expression at the NMJ has yet to be described in detail. 
The cellular source of Sema3A also remains somewhat elusive. In previous 
studies, two different research groups have pinpointed Sema3A expression to two 
different cell types. Using in situ hybridization, one group localized Sema3A mRNA 
expression to regions surrounding the NMJ. Histological evaluation identified Terminal 
Schwann Cells as the cellular source of Sema3A (De Winter et al., 2006). Conversely, 
through the use of a variety of in vitro and ex vivo models, another group has found that 
muscle stem cells can produce Sema3A in response to injury (Tatsumi et al., 2009). We 
have also tried to determine which cell type is responsible for Sema3A production using 
a variety of methods (generation of Sema3A-BAC-GFP mouse line, immunostaining, 
and immunoblotting), but we have not been able to successfully address this question. 
Interestingly, our RT-qPCR data raises questions about what cell type(s) express 
the various Sema3A signaling molecules. After sciatic nerve crush we found a specific 
reduction of both Sema3A and Npn1 mRNA in muscle tissue after injury. Furthermore, 
Npn1 expression was found to return to normal by day 30 after injury, but Sema3A 
mRNA levels remained diminished even at the latest time point examined. While the 
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reduction in Sema3A may indeed be explained by the fact that it is secreted by Terminal 
Schwann cells, our data suggests that some other population of cells in the muscle 
other than the motor axon must express Npn1 and be responsive to nerve crush. 
Furthermore, it is interesting that Sema3A mRNA levels did not return to baseline. This 
might reflect the fact that Sema3A levels do not normalize until the NMJ is fully 
remodeled, taking longer than 50 days for this to occur. Future studies to extend the 
analysis to later time points may help to address this question. 
Lastly, it is interesting that we could observe gene expression changes in 
Sema3A and Npn1 after nerve crush, but did not detect a functional consequence to 
altering Sema3A-Npn1 signaling. This might reflect the complexity and functional 
redundancy of mechanisms that underlie neuromuscular junction maintenance and 
regeneration. As discussed previously, many growth factors, morphogens, 
neurotrophins, and axon guidance molecules have been prescribed different roles at the 
NMJ during development and disease. Therefore, we cannot rule out the possibility that 
another mechanism is able to compensate for the loss of Sema3A-Npn1 signaling at the 
NMJ. Future studies to begin to address the role compensation plays at the NMJ may 
be useful in the identification of combinatorial strategies to improve regeneration and 
function. As the cost of RNA-sequencing (RNA-Seq) reduces, one strategy to identify 
compensatory pathways might entail examining transcriptional changes in motor 
neurons in the presence or absence of particular signaling molecules (i.e. Sema3A). 
Another strategy could include using CRISPR/Cas technology to alter multiple genes 
throughout the mouse genome at one time (Wang et al., 2013). By targeting multiple 
members within a family of signaling molecules (like Sema3A and Sema3F) or multiple 
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signaling pathways simultaneously (like Sema3s and EphrinAs), we might be able to 
identify synergistic ways to improve regeneration of the NMJ. 
 
Direct Targeting of Somatic Motor Neurons 
 To develop an unbiased means to assess motor neuron gene expression, we 
combined RiboTag technology (Sanz et al., 2009) with the choline-acetyltransferase 
(ChAT) promoter. Importantly, we characterized the methodology and demonstrated 
that it indeed allows for the specific isolation of motor neuron transcripts from the spinal 
cord. However, there is a minor limitation associated with the ChAT promoter because it 
labels cholinergic neurons other than somatic motor neurons. Therefore, new methods 
to limit analysis specifically to somatic motor neurons would improve the interpretation 
of future gene expression studies. 
 One such strategy to directly target somatic motor neurons would be through the 
use of retrograde viruses. For example, the adeno-associated virus 6 (AAV6) has been 
used to retrogradely drive gene expression in motor neurons (Kaplan et al., 2014). 
Therefore, performing intramuscular injections of an AAV6-Cre virus would specifically 
drive RPL22HA expression in motor neurons from discrete motor pools. Furthermore, 
driving Cre-mediated recombination in this manner would not only directly target 
somatic motor neurons, but would also provide the following advantages: 1) injecting 
virus only into one hindlimb would allow the contralateral limb to serve as an internal 
control; 2) it would eliminate the need to generate complex triple transgenic mouse lines 
to assess motor neuron gene expression with different genetic models; and 3) the 
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function of genes that are developmentally lethal could be examined in adult motor 
neurons by restricting the analysis to a small motor pool. 
 In addition to the targeted use of viruses to drive more specific Cre expression, 
our bioinformatics data from adult motor neurons may provide a strategy to discover 
novel genes restricted to somatic motor neurons. Examination of the heatmap 
comparing the most significantly enriched transcripts after RPL22HA immunoprecipitation 
(IP) to control IPs and whole cell lysates demonstrates that some genes are specifically 
enriched in the RPL22HA IP. Future characterization of those transcripts through in situ 
hybridization may lead to the identification of a new gene marker for somatic motor 
neurons. That information could then be used to derive a Cre-recombinase line. 
Importantly, this could be useful for both the RiboTag technology and it would generate 
a way to alter motor neuron gene expression with fewer off-target effects. 
 
Defining a Local Translatome for Motor Axons 
 There are currently two main models that allow for Translating Ribosome Affinity 
Purification (TRAP). First, BAC-TRAP mice were developed such that a tissue-specific 
promoter could drive the expression of an exogenous GFP-L10a ribosomal transgene 
(Heiman et al., 2008). Subsequently, the RiboTag model was developed to directly 
target the endogenous RPL22 protein (Sanz et al., 2009). Importantly, the key 
difference between the two models is how the epitope tagged ribosomal protein is 
produced. In the BAC-TRAP methodology, exogenous GFP-L10a must compete with its 
endogenous counterpart, which reduces the efficiency of incorporation into the 
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ribosome. Conversely, that problem is eliminated in the RiboTag model because it 
directly targets the endogenous RPL22 locus (Jung and Jung, 2016). 
 Despite the enhanced efficiency, here we report observations that there is a 
small degree of leaky RPL22HA expression in the absence of Cre. Although this does 
not impact the enrichment of tissue specific transcripts from populations that have 
abundant levels of translating RNA, it makes the analysis more challenging when the 
transcript abundance in the population under investigation is minute. As such, in our 
study of local translation of axons, we were not able to completely purify the axonal 
mRNAs from those associated with leaky RPL22HA. Despite this limitation, we were able 
to provide evidence that some axonal transcripts are indeed enriched in motor axons. 
Importantly, future analysis using in situ hybridization will be required to assess whether 
putative transcripts are truly locally translated in motor axons. 
 Finally, it is interesting to note that in a recent paper, the RiboTag Technology 
was successfully applied to study local translation in retinal ganglion cells (Shigeoka et 
al., 2016). In this report, the authors similarly observed that nonspecific RNAs associate 
with the HA IP in Cre-negative controls. However, the signal they captured after HA IP 
from Cre+ mice was much more enriched over the control compared to what we have 
observed in motor axons. While any number of things might account for these 
differences, age at isolation and tissue type may be crucial factors. Although local 
translation is involved in the normal maintenance of adult tissues, studies have 
generally found that it is more active at developmental stages and in response to injury 
(Willis and Twiss, 2006). Accordingly, Shigeoka et al., found that significantly more RNA 
was isolated from retinal ganglion cell axons during developmental axon pathfinding and 
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synaptogenesis than in the adult. Furthermore, tissue type might have also contributed 
to differences in the isolation efficiency because, compared to nervous system tissue, 
skeletal muscle contains a significant amount of connective and fibrous tissue that is 
challenging to homogenize. Together, these factors may help explain why it was more 
difficult to detect motor axon transcripts at adult NMJs. 
 In the future, studies of local translation in specialized compartments such as 
axons would benefit from the development of additional tools that avoid problems 
associated with leaky expression. In the meantime, given the methods currently at our 
disposal, it might be possible to improve the purification of transcripts from motor axons 
by focusing on injury models or development. 
 
Applicability to Models of Motor Nerve Injury and Neurodegeneration 
 Using the RiboTag;ChAT-Cre model we demonstrated that this technology can 
be applied to examine how motor neuron gene expression changes in response to both 
injury and neurodegeneration. Importantly, this opens the door to a broad array of 
exciting possibilities. Comparing how motor neurons respond to nerve crush, nerve cut, 
and neurodegeneration would be particularly illuminating. By understanding how these 
processes are similar and where they diverge may reveal novel strategies that can be 
used for the therapeutic treatment of peripheral nerve injury and neurodegenerative 
disease, such as amyotrophic lateral sclerosis (ALS). 
 In addition to comparing different injury paradigms, this strategy is well suited to 
dramatically expand our knowledge about how different forms of motor neuron disease 
(MND) affect motor neuron function. Although Superoxide dismutase 1 (SOD1) was the 
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first gene identified to cause ALS, work since has uncovered that mutations in many 
other genes can also result in ALS (Renton et al., 2014). Perhaps most importantly, the 
discovery that TARDBP, FUS, and C9ORF72 mutations lead to ALS has transformed 
our understanding of the molecular processes that lead to pathogenesis in MND. While 
SOD1 mutations initially highlighted oxidative stress and metabolic dysfunction as 
important pathways that result in MND (Sas et al., 2007; Johri and Beal, 2012; Ngo and 
Steyn, 2015), TARDBP, FUS, and C9ORF72 all encode proteins that are involved with 
RNA biogenesis and trafficking (Yasuda and Mili, 2016). Given disparate molecular 
etiologies, the degree to which these MNDs should be painted with the same brush has 
lately come into question (Mackenzie et al., 2007; Renton et al., 2014). Therefore, 
although we have initially crossed the SOD1G93A model to the RiboTag;ChAT-Cre 
mouse line, future experiments incorporating other forms of MND may help to uncover 
key differences in pathogenesis. Given that TARDBP, FUS, and C9ORF72 have all 
been linked to RNA metabolism and processing, exploring how local translation is 
affected in motor axons in those models will be particularly interesting.  
 Finally, in addition to examining transcripts that are associated with ribosomes in 
motor neurons, we also demonstrated that the RiboTag technique can be applied to 
examine other translational proteins that associate with the IP. We have initially done 
this through the examination of phosphorylated-S6 ribosomal protein (pS6). Importantly, 
association of p-S6 in the ribosomal complex has been used as marker of translationally 
active ribosomes (Kalinski et al., 2015). Examination of p-S6 in the co-IP revealed that it 
was indeed associated with RPL22HA after injury in motor axons. Furthermore, we also 
found an increase in p-S6 association at an early symptomatic time point in SOD1G93A 
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mice, while it was undetectable at the terminal time point. Future studies into the 
association of p-S6 and other translational proteins may be applied to reveal how the 
process of translation itself is altered in injury and disease. In line with this, the idea that 
ribosomal complexes are not homogeneous has given rise to the idea of a “ribocode” in 
which specification of ribosomes may tune them to translate specific mRNAs under 
different contexts (Xue and Barna, 2012; Holt and Schuman, 2013). Therefore, 
examining the proteins that associate with the RPL22HA IP in different conditions may 




 Through the work presented here we highlighted just some of the molecular 
mechanisms that regulate motor neuron innervation at the NMJ. Our examination of 
Sema3A signaling suggests that it has more limited therapeutic potential than previous 
studies suggested. Additionally, the development of a model to quantitatively assess 
NMJ reinnervation and a method to assess motor neuron specific gene expression will 
be valuable tools for future research. Applying these methods to better understand how 
motor neurons respond to injury and neurodegeneration could lead to promising 
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